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ABSTRACT 
Components of G protein-mediated signaling are associated with positioning and orienting the 
mitotic spindle in the process of cell division. However, a functional role for G protein signaling 
modulator 3 (GPSM3) in cell division has yet to be defined. The purpose of this study was to 
investigate a potential role for GPSM3 in cell division. Vascular smooth muscle cells (VSMCs) 
from Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats, that are known to 
express GPSM3, were used as a model system. Here I report that GPSM3 mRNA and protein 
levels varied during different stages of the cell cycle in SHR VSMCs. In HEK-293 cells, 
overexpressing GPSM3 resulted in an increased rate of proliferation. Finally, during metaphase, 
anaphase, and telophase, GPSM3 and β-tubulin co-localize at the mitotic spindle and midbody. 
Overall, this study provides evidence of a role for GPSM3 in cell division, likely via an 
interaction with the mitotic spindle.    
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1 INTRODUCTION 
 
The functional role of G protein signaling modulator 3 (GPSM3) in mammalian cells remains 
poorly understood relative to other components of the G protein-mediated signaling machinery. I 
hypothesize that GPSM3, like other G protein-mediated signaling components, plays a role in the 
process of cell division, likely via an as yet undefined interaction with the mitotic spindle. The 
purpose of this study is to investigate this potential role in a vascular smooth muscle cell 
(VSMC) model system. 
 
1.1 G PROTEIN SIGNALING 
1.1.1 G PROTEIN SIGNALING OVERVIEW 
 
Guanine nucleotide-binding protein (G protein)-mediated signaling is a preeminent mechanism 
used by cells to communicate with each other and sense environmental changes. Canonically, 
signaling occurs through three main protein components: a G protein-coupled receptor (GPCR), 
a heterotrimeric G protein (Gαβγ), and an effector (Neves et al. 2002; Ferguson 2001; Jacoby et 
al. 2006) (Figure 1.1).  Briefly, when a GPCR is activated by its ligand, it promotes the exchange 
of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) by the α subunit of the 
heterotrimeric G protein. This in turn is thought to promote the dissociation of the Gα and Gβγ 
subunits, which are then free to independently shuttle to and interact with downstream effectors. 
Examples of effectors include adenylyl cyclase (AC), which plays a central role in the cyclic 
adenosine monophosphate (cAMP) signal pathway, and phospholipase Cβ (PLCβ), which  
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Figure 1.1. Receptor-mediated activation of heterotrimeric G proteins. The binding of the 
extracellular ligand to the receptor causes a conformational; change of the receptor, which leads 
to the activation of the Gα subunit. This activation promotes the exchange of GDP for GTP and 
is thought to cause the dissociation of the Gβγ dimer from the complex. Both the GTP-bound Gα 
and Gβγ subunit are capable of initiating signals by interacting with downstream effectors. The 
process is terminated by the GTPase activity of the Gα subunit that can hydrolyze GTP to GDP, 
returning the Gα subunit to its inactive form and promoting the reformation of the Gαβγ 
heterotrimer complex.  
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triggers the phosphatidylinositol/diacylglycerol signal pathway (Neves et al. 2002; Smrcka 
2008). Eventually, the intrinsic guanosine triphosphate phosphohydrolase (GTPase) activity of 
Gα will hydrolyze the bound GTP molecule, which results in the reformation of the Gαβγ 
complex and terminates GPCR signaling. 
 
1.1.2 G PROTEIN COUPLED RECEPTORS 
 
GPCRs are the largest superfamily of receptors in the human genome and approximately 30% of 
currently marketed prescription pharmaceuticals act on GPCRs, making them the most common 
and historically successful therapeutic target family (some reports place this number closer to 
50%) (Jacoby et al. 2006; Overington et al. 2006; Kobilka 2007). These receptors transduce a 
wide variety of extracellular signals, including hormones, autocrine and paracrine factors, 
chemokines, and neurotransmitters, to the interior of the cell (Neves et al. 2002). GPCRs share a 
specific structural organization: seven membrane-spanning domains or transmembrane alpha 
helices connected by three intracellular loops and three extracellular loops, an N-terminal 
extracellular tail, and a C-terminal intracellular tail (Jastrzebska 2013). Many GPCRs also 
possess an eighth alpha helix attached by a linker to helix seven that runs parallel to the inside of 
the phospholipid bilayer which can influence G protein recognition (Kaye et al. 2011).  
 
When a GPCR is activated by a ligand, typically via binding in a cavity formed between the 
transmembrane helices, conformational changes occur at its cytoplasmic surface that reveal 
residues in the intracellular loops and in the transmembrane helices that lead to G protein 
activation (Jastrzebska 2013; Trzaskowski et al. 2012). GPCRs activate G proteins by acting as 
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guanine nucleotide exchange factors (GEF), promoting the exchange of GDP for GTP on the Gα 
subunit (Siderovski & Willard 2005). Activated GPCRs can be phosphorylated by G protein-
coupled receptor kinases (GRKs), and that promotes their association with β-arrestins (Ferguson 
2001; DeWire et al. 2007). These proteins block GPCR signaling through a steric mechanism 
and bring the receptors to clathrin-coated pits for internalization. Once internalized in 
endosomes, GPCRs can undergo degradation, continue signaling via G protein-independent 
mechanisms, or be recycled back to the plasma membrane. While this traditional view of GPCRs 
begins to outline their function, there are numerous additional facets to the story that illustrate 
the complexity of this process including the now widely accepted phenomenon of GPCR 
oligomerization and the evidence for receptor-G protein-effector complexes (Jastrzebska 2013; 
Chidiac 1998).  
 
1.1.3 DIVERSITY OF Gα PROTEINS AND SIGNALING  
 
Up to the present time, 23 Gα subunit isoforms have been identified (McIntire 2009; Preininger 
& Hamm 2004). Gα subunits belong to a family of membrane-associated GTPases that function 
as molecular switches to control a wide array of cellular processes, and have been placed into 
four distinct subfamilies based on their sequence similarity and effector selectivity: Gs, Gi/o, 
Gq/11, and G12/13 (Neves et al. 2002; Zhao et al. 2013) (Table 1.1) (Figure 1.2). Gs subunits 
(Gαs, Gαolf) can stimulate AC activity, increasing cAMP production (Neves et al. 2002). This 
second messenger is capable of regulating proteins such as cAMP-dependent protein kinase 
(PKA), cAMP-dependent GEFs for calcium channels and a small GTPase known as Ras-related 
protein 1 (Rap1) (Weinstein et al. 2004; Neves et al. 2002). Gαs has also been found to interact  
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Table 1.1. Classes of Gα subunits, their expression pattern, and their effectors. 
Gα family Gα 
subunit 
Expression Profile Effectors 
Gαs 
Gαs Ubiquitous Stimulation of adenylyl cyclase 
Gαolf Olfactory neurons Stimulation of adenylyl cyclase 
Gαi/o 
Gαi1/2/3 Ubiquitous Inhibition of adenylyl cyclase, Ca2+ 
channel closure 
GαoA/B Brain Inhibition of adenylyl cyclase, Ca2+ 
channel closure 
Gαt1/2 Retina Stimulation of cGMP-
phosphodiesterase 
Gαz Brain/platelets Inhibition of adenylyl cyclase, K+ 
channel closure 
Gαq/11 
Gαq/11 Ubiquitous Stimulation of PLC-β, Activate 
RhoGEFs* 
Gα15/16 Hematopoietic cells Stimulation of PLC-β, Activate 
RhoGEFs* 
Gα14 Lung, kidney, liver Stimulation of PLC-β, Activate 
RhoGEFs* 
Gα12/13 Gα12/13 Ubiquitous Activate RhoGEFs* 
* RhoGEFs activated by Gα12/13 and Gα14 are distinct. 
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Figure 1.2. Regulation of systemic functions by signaling through G protein pathways. A 
schematic representation of how signaling through G protein pathways can regulate systemic 
functions. From Neves et al. 2002. Reprinted with permission from AAAS.  
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with tubulin in lipid rafts and can be internalized via lipid raft-derived vesicles (Dave et al. 
2009). Members of the Gi/o subfamily (Gαi1, Gαi2, Gαi3, Gαo, Gαz, Gαt) exhibit inhibitory 
effects on AC activity, thereby decreasing cAMP production (Neves et al. 2002). Gαi/o subunits 
also play an important role in the process of cell division. The Gαi and Gαo subunits can be 
inhibited by pertussis toxin, which adenosine diphosphate (ADP)-ribosylates Gαi/o subunits at 
their COOH-terminal region preventing them from interacting with a GPCR (Neves et al. 2002). 
Gq subunits (Gαq, Gα11, Gα14, Gα15, Gα16) primarily act on PLCβ leading to the production 
of two intracellular second messengers, inositol triphosphate (IP3) and diacylglycerol (DAG), 
and via these the regulation of the release of intracellular calcium stores and the activity of 
protein kinase C (PKC), respectively (Neves et al. 2002; Rhee & Bae 1997). The effectors of 
G12/13 subunits (Gα12, Gα13) are not yet well understood, but have been shown to regulate 
Rho, a member of the Ras superfamily, and Rho-kinase activation via RhoGEFs (Neves et al. 
2002). 
 
1.1.4 STRUCTURAL BASIS OF Gα PROTEIN ACTIVATION  
 
Gα protein subunits consist of a catalytic (Ras-like or GTPase) domain, a six-helix bundle 
domain (helical domain), and two flexible linker regions (linkers 1 and 2), connecting these two 
domains whose interface forms a deep cleft which functions as a GDP binding pocket (Figure 
1.3) (Khafizov 2009; Lambright et al. 1994). The GTPase domain is made up of five helices (α1-
α5) surrounding a six-stranded β sheet (β1-β6), while the helical domain is comprised entirely of 
α-helical secondary structures with one long central helix (αA) encompassed by five shorter 
helices (αB-αF) (Lambright et al. 1994). The three flexible loops (Switches I, II, and III) within 
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Figure 1.3. Structural features of heterotrimeric G proteins. (a) Ribbon model of 
Gαi(GDP)β1γ1 heterotrimer. (b) The subunits have been rotated to show the intersubunit 
interface. From Oldham & Hamm 2006. Reprinted with permission from Cambridge University 
Press.  
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the GTPase domain undergo dramatic structural changes during the nucleotide exchange and 
hydrolysis cycle (Lambright et al. 1994; Mixon et al. 1995). The GTPase domain also contains 
binding sites for various receptors and effectors, as well as Gβγ. An α-helical lid, part of the 
helical domain, is positioned over the nucleotide binding site, burying the bound nucleotide in 
the core of the protein (Lambright et al. 1994; Warner et al. 1998). The helical domain is the 
most divergent domain among the Gα subunit families and therefore is thought to regulate 
binding of Gα subunits to receptors and other regulators (Liu & Northup 1998).  
 
Upon activation by a ligand, it has been suggested that the GPCR uses the N-terminal helix of 
Gα to “pull” the Gβγ dimer and switch I and II regions away from the nucleotide binding pocket, 
resulting in GDP release (Iiri et al. 1998). Non-receptor GEFs such as resistance to inhibitors of 
cholinesterase 8 (Ric-8) work in a similar manner, promoting the pivoting of the helical and Ras-
like domains away from each other and structural rearrangement of the switch I and II regions to 
allow for nucleotide exchange (Van Eps et al. 2015). The Gα subunit most likely exists in a 
transient nucleotide-free state before binding of GTP, which exists at a much higher 
concentration in the cell relative to GDP (Smrcka 2008). The binding of GTP results in structural 
rearrangement of the heterotrimeric G protein that exposes the Gα subunit’s effector binding site, 
thus leading to signal transduction. The duration of G protein signaling is determined by the 
length of time that the Gα subunit is in its GTP-bound state (Ross & Wilkie 2000). The intrinsic 
GTP hydrolysis activity among the different Gα protein subunits varies, although it is relatively 
slow in all cases compared to when it is stimulated by GTPase-accelerating proteins (GAP), 
which often occurs (Oldham & Hamm 2006). Structural studies have demonstrated the 
importance of the three switch regions in GTP hydrolysis, and inspection of the crystal structure 
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of fluoroaluminate-activated Gα protein subunit reveals a functional role of conserved glutamine 
and arginine residues within the nucleotide-binding pocket (Coleman et al. 1994; Noel et al. 
1993; Sondek et al. 1994). 
 
1.1.5 DIVERSITY OF Gβγ SIGNALING 
 
Gβ and Gγ subunits, tethered to the membrane by fatty acyl modification of Gγ, essentially 
function as dimers since the Gβγ complex is highly stable and only comes apart under denaturing 
conditions (Zhao et al. 2013; Neves et al. 2002). Up to the present time, 7 β subunit and 12 γ 
subunit isoforms have been identified (McIntire 2009). The first five β subunits are the most well 
studied, with the first four sharing greater than 80% amino acid sequence identify versus the fifth 
with 50% identity, and significantly lower identity amongst the γ subunits (Smrcka 2008). These 
different subunit isoforms can pair to form unique combinations; some combinations have been 
associated with specific receptors, but overall the significance of this diversity remains poorly 
understood (Kleuss et al. 1992; Kleuss et al. 1993).  
 
Pertussis toxin (PTX)-dependent catalysis of adenosine diphosphate (ADP) ribosylation of Gαi/o 
subunits prevents their interaction with and activation by GPCRs (Burns 1988). Many of the 
GPCR-dependent physiological processes that are inhibited by PTX are mediated by Gβγ 
subunits rather than Gα subunits, and this accounts for the majority of known Gβγ-dependent 
signaling. Therefore it follows that the majority of Gβγ-dependent signaling appears to result 
from Gβγ dimers originally complexed with Gαi/o protein subunits (Smrcka 2008).  
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Gβγ is required for receptor-stimulated activation since it stabilizes Gα-receptor coupling, and 
has even been reported to bind to the receptor (Zhao et al. 2013; Smrcka 2008). Gβγ dimers also 
act as guanine nucleotide dissociation inhibitors (GDI), slowing down the intrinsic rate of GDP 
dissociation from the Gα subunit by up fifty fold, as well as functioning to increase the rate of 
association of GDP (Gilman 1987). Gβγ targets a large number of effectors both directly and 
indirectly, including G protein-coupled inwardly rectifying K+ (GIRK) channels, PLCβ, AC, and 
various kinases and calcium channels (Smrcka 2008; Rhee & Bae 1997) (Table 1.2). Gβγ 
specificity for receptors and effectors is poorly understood, but suggested mechanisms include 
tissue-specific expression, restricted subcellular localization, and precoupling of components 
(Smrcka 2008).  
 
1.1.6  STRUCTURAL BASIS OF Gβγ SIGNALING 
 
The Gβ subunit folds into a protypical β-propeller made up of four-stranded β-sheets forming 
each of the seven blades of the propeller (Smrcka 2008) (Figure 1.3). An α-helical domain, 
comprised of the first 57-70 amino acids N-terminal to the β-propeller, forms a tight coiled-coil 
interaction with the Gγ subunit (Smrcka 2008). The β-sheets of the propeller and the variable 
loops connecting the β strands are the most highly conserved regions of the protein (Smrcka 
2008). Gα subunits interact with Gβγ via two independent structural elements: the N-terminal α-
helix of the Gα subunit interacts with the first blade of the β-propeller at its side and the Gα 
switch II region interacts with the top of the β-propeller (Smrcka 2008). Upon GTP binding, the 
switch II region undergoes conformational changes, but little difference in structure is seen in 
Gβγ upon release from Gα (Smrcka 2008). This supports a theory that rather than dissociate, the 
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Gαβγ heterotrimer simply undergoes a rearrangement during G protein activation. However, the 
more generally accepted theory of complete dissociation asserts that during activation both 
interfaces between Gα and Gβγ are broken. In either case, traditionally it is taken that when 
bound to Gα(GDP), Gβγ cannot activate downstream effectors and thus Gβγ-mediated signaling 
relies on nucleotide exchange on the Gα subunit (Scott et al. 2001). In a sense, Gα(GDP) and 
Gβγ are locked in a mutually inhibitory embrace with one another. However, an apparent second 
Gβγ binding site on Gαi/o subunits, which is distant from the primary site and does not compete 
with the principal effector binding site, suggests that a Gαi/o(GDP)-(Gβγ)2 complex could 
associate with effectors (Wang et al. 2009).  
 
The absence of a catalytic site on Gβγ means that it acts as a modulator through regulated 
protein-protein interactions (Smrcka 2008). It has been suggested that the majority of these 
interactions occur at a single interaction “hot spot”, which through the use of key energetic 
residues mediates multiple types of chemical interactions (hydrophobic, ionic, etc.) without strict 
geometric requirements for binding, thus accommodating multiple structural and chemical motifs 
(Scott et al. 2001; Smrcka 2008).  
 
1.1.7 KINETIC REGULATION OF G PROTEIN ACTIVITY 
 
The kinetics of the G protein activation and deactivation reactions play a major role in G protein-
mediated signaling. G proteins are normally found in the GDP-bound state and thus the first step 
in the cycle of nucleotide exchange at the Gα subunit is GDP dissociation. The relatively high 
concentration of GTP in cells (both absolute concentration and relative concentration compared 
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to GDP) ensures a rapid association of the nucleotide-free G protein with GTP (Smrcka 2008). 
This means that GDP dissociation is the rate-limiting step of nucleotide exchange. GTP is 
typically hydrolyzed before it dissociates, thus beginning the cycle again. Three classes of 
regulators collaborate to tightly control the kinetics of G protein signaling: GAPs, GEFs, and 
GDIs (Figure 1.4).   
 
GAPs such as the regulator of G protein signaling (RGS) proteins can increase GTP hydrolysis 
rates by up to 2000 fold (Mukhopadhyay & Ross 1999). Consequently, GAP proteins negatively 
regulate the G protein cycle by dampening signal output and by rapidly terminating G protein 
activation following the removal of the stimulus. It is also suspected that GAP proteins, namely 
RGS proteins, are able to potentiate receptor-mediated activation via a proposed kinetic 
scaffolding mechanism whereby they reduce depletion of Gα(GDP) levels in order to ensure 
rapid recoupling to the receptor and sustained G protein activation (Biddlecome et al. 1996; 
Zhong et al. 2003). They could potentially even directly or indirectly interact with GPCRs during 
nucleotide exchange (Lambert et al. 2010; Popov et al. 2000).  
 
GEFs such as GPCRS dramatically increase the rate of GDP dissociation, leading to an increase 
in GTP association and G protein activation. Non-receptor GEFs such as Ric-8 share similar 
mechanisms with that of the receptor, promoting the dissociation of both GDP and GTP (Chan et 
al. 2011). At high GTP concentrations, such as those found intracellularly (~150 µM), GTP 
association is greater than dissociation and Gα(GTP) predominates (Chan et al. 2011). 
Interestingly, Ric-8B has also been reported to seemingly stabilize G proteins in their nucleotide- 
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Figure 1.4. Regulation of G protein cycle. The rate of nucleotide exchange can be altered by 
guanine nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors 
(GDIs). GTP hydrolysis can be regulated by GTPase accelerating proteins (GAPs).  
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free conformation, preventing them from denaturing and thereby increasing cellular G protein 
levels (Tall 2013). 
 
Finally, GDIs such as Gβγ retard the already relatively slow rate of GDP dissociation from Gα 
(Zhao et al. 2013). Proteins containing the G protein signaling modulator (GPSM) motif, also 
known as a G protein regulatory (GPR) motif or a GoLoco (Gαi/o-Loco) motif, are the best 
studied group of proteins with GDI activity (Granderath et al. 1999; Siderovski et al. 1999; Zhao 
et al. 2013). It has been reported that the rate of guanosine 5’-O-[gamma-thio] triphosphate 
(GTPγS, a GTP analog which dissociates slowly and cannot be hydrolyzed to GDP) binding is 
decreased up to 80% in the presence of GPSM proteins (including GPSM3) or peptides derived 
from the GPSM motifs of RGS12 and RGS14 (Zhao et al. 2010; Windh & Manning 2002). They 
accomplish this by directly interacting with and stabilizing Gα(GDP). These three groups of 
accessory proteins fine-tune G protein signaling, and as discussed below they have a wide range 
of other functions in the cell as well.  
 
1.2 GPSM MOTIF-CONTAINING PROTEINS 
1.2.1 IDENTIFICATION AND CHARACTERIZATION OF GPSM MOTIF-CONTAINING 
PROTEINS 
 
The first GPSM motif identified is in loco, a RGS12 homologue found in Drosophila 
melanogaster and associated with impaired locomotor capabilities (Granderath et al. 1999). C-
terminal to its RGS domain the researchers identified a G protein interaction site, and this 
observation led to the discovery of several other proteins that shared this highly conserved 19 
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amino acid motif (Granderath et al. 1999; Siderovski et al. 1999). This motif was also quickly 
demonstrated to be a receptor-independent activator of Gβγ signaling. A yeast-based functional 
screen was used to take advantage of this, which tested a mammalian library for cDNAs 
encoding proteins that activate the pheromone response pathway in the absence of a GPCR. This 
led to the discovery of the AGS proteins, many of which contain at least one GPSM motif 
(Takesono et al. 1999; Cao et al. 2004).   
 
The GPSM motif has a relatively high affinity for GDP-bound Gα compared to nucleotide-free 
or GTP-bound Gα, stabilizing this form and slowing down spontaneous nucleotide exchange 
(Kimple, Willard, et al. 2002; Kimple, Kimple, et al. 2002; Siderovski & Willard 2005). A 
significant conformational change of the switch region of the Gα subunit is induced upon 
binding of a GPSM domain, making Gα(GDP)-Gβγ and Gα(GDP)-GPSM complexes mutually 
exclusive (Bernard et al. 2001; Siderovski & Willard 2005). A GPSM motif consensus peptide 
that was derived from GPSM1, also known as activator of G protein signaling (AGS) 3, inhibits 
Gα(GDP) from binding to Gβγ ten times more effectively than the Gβγ hot spot-binding peptide 
(SIGK, which also interferes with the binding between Gβγ and Gα) (Ghosh et al. 2003). 
Additionally, this peptide was shown to cause rapid dissociation between Gβγ subunits and Gα 
subunits at a rate 13-fold higher than the intrinsic rate of Gα (Ghosh et al. 2003). Full-length 
RGS14 failed to disrupt G protein heterotrimers in vitro or in cells, but a peptide derived from 
the RGS14 GPSM motif prevented the reformation of Gαβγ heterotrimers (Mittal & Linder 
2006; Webb et al. 2005). While the GPSM motif seems to consistently prevent reassociation of 
subunits, its ability to promote dissociation appears to depend on the cellular or experimental 
context and the GPSM motif-containing protein in question.  
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1.2.2 DIVERSITY OF GPSM MOTIF-CONTAINING PROTEINS 
 
The diverse collection of GPSM-motif containing proteins is currently divided into four distinct 
families: 1) the RGS and Ras-binding domain (RBD) proteins RGS12, RGS14, and Drosophila 
Loco, each of which contains a single GPSM motif, 2) the multiple tetratricopeptide repeat 
(TPR) motif proteins GPSM1/AGS3, GPSM2/LGN, Drosophila Partner of Inscuteable (Pins), 
and Caenorhabditis elegans GPR-1 and GPR-2, which contain one to four GPSM motifs, 3) the 
relatively small proteins GPSM3/G18/AGS4 and GPSM4/Pcp-2, which contain three and two 
GPSM motifs, respectively, and 4) Rap1GAP, which contains a single GPSM motif at its N-
terminus (Figure 1.5).  
 
The majority of the GPSM motifs interact mainly with Gαi and Gαo with varying affinities, 
however some also interact with other G proteins (Zhao et al. 2010; Mittal & Linder 2006; 
Willard et al. 2006; Willard et al. 2007). GPSM1, for example, interacts with Gαt and blocks 
rhodopsin-induced dissociation of GDP (Natochin & Artemyev 2000). Therefore, the GPSM 
motif can be said to interact with G proteins from the Gαi/o subunit family. As many of these 
proteins contain multiple GPSM motifs, they are capable of binding multiple Gα subunits at one 
time (Bernard et al. 2001; Adhikari & Sprang 2003; Kimple et al. 2004; Jia et al. 2012). It 
appears that in GPSM1, cooperative binding of Gα subunits among its GPSM motifs occurs 
(Adhikari & Sprang 2003). Conversely, competitive binding among the GPSM motifs in Pins has 
been demonstrated and is thought to contribute to ultrasensitivity in regulatory pathways (Smith 
& Prehoda 2011). 
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Figure 1.5. Diversity of GPSM motif-containing proteins. The GPSM motif, also known as 
the GPR motif or GoLoco motif, is found singly or in tandem arrays in a number of different 
proteins. Domain abbreviations are G protein signaling modulator, GPSM; PSD-95/Discs 
large/ZO-1 homology domain, PDZ; phosphotyrosine-binding domain, PTB; regulator of G 
protein signaling domain, RGS; Ras-binding domain, RBD; Rap-specific GTPase-activating 
protein domain, RapGAP; tetratricopeptide repeat, TPR. Asterisk denotes N-terminal variation of 
GPSM motif sequence between isoforms I and II of Rap1GAP.  
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1.2.3 MOLECULAR BASIS FOR THE GDI ACTIVITY OF GPSM MOTIF- CONTAINING 
PROTEINS 
 
The crystal structure of the GPSM motif in RGS14 associated with Gαi1 demonstrates the 
significance of both the Asp/Glu-Gln-Arg triad (or acidic-glutamine-arginine triad) of the GPSM 
motif and the switch II region of the Gα subunit (Kimple, Kimple, et al. 2002) (Figure 1.6). The 
N-terminal α-helix of the GPSM peptide inserts between the switch II and α3 helix regions of the 
Gα subunit, displacing these two regions away from each other and in the process deforming the 
normal site of Gβγ association. The side chain of the arginine finger within the acidic-glutamine-
arginine triad, which defines the final residues of the conserved 19 amino acid GPSM motif 
signature, reaches into the nucleotide binding pocket of Gα and makes direct contact with the α 
and β phosphate of the bound GDP via its basic δ-guanididium group (Kimple, Kimple, et al. 
2002; Siderovski & Willard 2005; Thomas et al. 2008). It has also been shown that the binding 
of the GPSM motif displaces an arginine within the switch I region of Gα, and instead of 
contacting the α and β phosphate groups it contacts the 3’ hydroxyl group of the GDP ribose 
sugar moiety (Willard et al. 2004). This newly formed interaction is believed to underlie the GDI 
activity of the GPSM motif.  
 
Mutation of the arginine in the acidic-glutamine-arginine triad to phenylalanine results in the 
complete loss of GDI activity and the ability to bind Gαi/o subunits, while mutation to less bulky 
alanine or leucine residues causes a significant decrease in GDI activity but no change in binding 
affinity  
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Figure 1.6. The GPSM motif of RGS14 interacts with Gαi1. Ribbon drawing of R14GL 
peptide (red) in contact with the Ras-like (green) and all-helical (yellow) domains of Gαi1. Also 
shown are the three switch regions of Gαi1 (blue), GDP (magenta), and Mg2+ (orange). From 
Kimple, Kimple, et al. 2002. Reprinted with permission from Nature Publishing Group. 
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(Kimple, Kimple, et al. 2002; Peterson et al. 2000; Takesono et al. 1999; Peterson et al. 2002; 
Bernard et al. 2001). This means that the arginine of the acidic-glutamine-arginine triad is a 
significant, but not an absolute, determinant of guanine nucleotide dissociation inhibitor activity 
(Willard et al. 2004). The glutamine residue preceding it is also a crucial determinant of GDI 
activity, forming extensive backbone interactions with the Gα subunit which kinks the GPSM 
motif peptide backbone allowing the arginine side chain to fully extend into the nucleotide-
binding pocket (Kimple, Kimple, et al. 2002; Willard et al. 2004). Mutating this residue to 
alanine eliminates GDI activity and Gα binding (Peterson et al. 2002). Finally, the acidic residue 
preceding glutamine is important for structurally anchoring glutamine via a side chain hydrogen 
bond (Willard et al. 2004).  
 
The selectivity of the various GPSM motifs for G proteins is determined principally by the all-
helical domain of the Gα subunit and residues C-terminal to the conserved 19 amino acid core 
GPSM motif. A Gαo-insensitive GPSM motif peptide derived from RGS14 and GPSM1 
exhibited GDI activity on a chimeric Gαo subunit containing the all-helical domain of Gαi1 
(Kimple, Kimple, et al. 2002). Alternatively, replacing the C-terminal domain of RGS14 with the 
corresponding region from Pcp-2, a GPSM motif-containing protein that is sensitive to Gαo, 
leads to a gain of function similar to wild-type Pcp-2 (Kimple, Kimple, et al. 2002). 
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1.2.4 REGULATION OF GPSM MOTIF FUNCTION 
 
Although the regulation of GPSM motif function remains poorly studied, a few forms of 
regulation have been identified. Most GPSM motif-containing proteins contain at least one 
phosphorylation site located within or N-terminal to the core GPSM motif, which theoretically 
could affect their function. Phosphorylation of the PKA substrate Thr-494 just N-terminal to the 
GPSM motif of RGS14 results in increased GDI activity by up to three fold (Hollinger et al. 
2003).  Phosphorylation of the GPSM motifs in GPSM1 by LKB1, on the other hand, reduces its 
ability to interact with G proteins (Blumer et al. 2003). Phosphorylation of the Thr-450 site N-
terminal to the first GPSM motif in GPSM2 by PBK/TOPK leads to enhanced cell growth 
(Fukukawa et al. 2010a). Whether this effect is related to G protein signaling or the Gα-GPSM2-
NuMA ternary complex is unclear. It therefore appears that phosphorylation is a commonly used 
means to regulate GPSM motif-containing proteins (Blumer et al. 2007).  
 
Expression of some GPSM motif-containing proteins appears to be developmentally regulated. 
GPSM1 mRNA levels in the heart change during the course of development, and expression has 
been shown to decline in the aging rat brain (Pizzinat et al. 2001; Blumer et al. 2002). GPSM1 is 
also upregulated in the brain of a rat model of craving following cocaine exposure (Bowers et al. 
2004). GPSM2 expression has been reported to change with the cell cycle (Whitfield et al. 2002; 
Du & Macara 2004).  
 
Regulation via the activation of GPCRs has also been demonstrated. Activation of the α2 
adrenergic receptor (α2-AR) or the µ-opioid receptor greatly diminishes the bioluminescence 
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resonance energy transfer (BRET) signal observed between GPSM1 and Gαi. Interestingly, co-
expression of RGS4 in this overexpression system inhibits this effect, suggesting that both 
nucleotide exchange and hydrolysis play a role in this regulatory effect (Oner, An, et al. 2010). 
Coupling between GPSM3 and Gαi is also reported to be reduced upon activation of the α2-AR 
(Oner, Maher, et al. 2010). Recently, evidence has been found that this regulation may be the 
result of direct coupling of a GPSM-Gα(GDP) complex with a GPCR, suggesting this could 
represent a unique signaling triad that parallels the well-defined heptahelical receptor-Gαβγ-
effector system (Robichaux et al. 2015). This study used a version of Gαi2 that was mutated to 
be pertussis toxin-insensitive and tethered to α2-AR. Pertussis toxin was used to ensure that only 
the tethered Gα subunits were being tested. When bound by either GPSM3 or GPSM1, agonist 
activation was shown to reduce BRET signals between both of these proteins and Gαi2 by up to 
40%. This is an intriguing result as many GPSM-motif containing proteins have more than one 
GPSM motif, and could therefore bind multiple Gα subunits and could conceivably act to 
scaffold associated receptors. It has also been reported that GPSM-Gα(GDP) complexes can be 
regulated by non-receptor GEFs such as Ric-8A, catalyzing the separation of GPSM motifs from 
Gα(GDP) in both GPSM1 and GPSM2, with an apparent preference for myristoylated Gα 
subunits (Thomas et al. 2008; Tall & Gilman 2005). It should be noted that while Ric-8A does 
bind to GPSM1, it has not always been shown to facilitate Gαi-induced suppression of adenylyl 
cyclase and thus may not always act as a GEF in a cellular environment (Tse et al. 2015). RGS7 
appears to oppose this process, promoting the reassociation of Gα(GDP) with GPSM-motif 
containing proteins (Tall & Gilman 2005). 
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Regulation of GPSM motif function can also occur via the action of other GPSM motifs within 
the same protein.  These additional motifs can create an ultrasensitivity by acting as competitive 
decoys, competing against the activation of the functionally relevant GPSM motif (Lu et al. 
2012; Smith & Prehoda 2011). High-affinity decoy sites add a threshold to the response, while 
low-affinity decoy sites contribute the ultrasensitive component by ensuring a sigmoidal 
response.  
 
1.2.5 CELLULAR FUNCTIONS OF GPSM MOTIF-CONTAINING PROTEINS 
 
Functional studies of GPSM motif-containing proteins indicate their involvement in a wide range 
of physiological roles, including cell division, neuronal outgrowth, craving and addiction, 
autophagy, and ion channel regulation (Blumer et al. 2007). GPSM1 is upregulated in the 
prefrontal cortex of rats during late withdrawal following repeated cocaine exposure (Bowers et 
al. 2004). It has therefore been suggested that GPSM1 regulates cocaine-induced behavioral 
plasticity via G protein signaling in the prefrontal cortex. GPSM1 has also been linked to early 
events in the autophagic pathway in human intestinal HT-29 cells, likely prior to autophagosome 
formation (Pattingre et al. 2003). The influence of GPSM motif-containing proteins on G 
protein-regulated ion channels has been investigated in both HEK293 cells and X. laevis oocytes 
expressing GIRK channels. Full-length GPSM2 and peptides derived from its GPSM motifs 
activate basal Gβγ-dependent K+ currents, while siRNA knockdown of GPSM2 decreased basal 
K+ currents in primary neuronal cultures (Wiser et al. 2006). Pcp-2 modulated receptor 
regulation of Cav2.1 calcium channels expressed in X. laevis oocytes, but had no effect on the 
basal current (Kinoshita-Kawada et al. 2004). Complexes between Gαi(GDP) and the GPSM 
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regions of GPSM1, Pins, and GPSM2 have been found to regulate both Drosophila and 
mammalian asymmetric cell division (ACD). This will be discussed in greater later.  
 
GPSM motif-containing proteins may also play a role in hypertension. Altered Gαi/o mediated 
cell signaling has been linked to hypertension; in fact, an increased level of Gαi is one of the 
earliest events in animal models of hypertension (Sato & Ishikawa 2010; Anand-Srivastava 
1996). In the aorta of 6 week old spontaneously hypertensive (SHR) rats, expression of Gαi was 
increased by 40% compared to that in normotensive Wistar-Kyoto (WKY) rats (Anand-
Srivastava 1992). Uncoupling of GPCRs and Gαi via treatment with pertussis toxin normalizes 
the expression of Gαi in SHR rats and results in the reduction of blood pressure to normotensive 
levels, delaying the onset of hypertension (Li & Anand-Srivastava 2002; Kost et al. 1999). 
GPSM1 null mice exhibit altered blood pressure control mechanisms, including increased 
baroreceptor reflex sensitivity and an inability to restore arterial pressure following treatment 
with the vasodilating agent sodium nitroprusside (Blumer et al. 2008).  
 
1.3 ASYMMETRIC CELL DIVISION 
1.3.1 ASYMMETRIC CELL DIVISION OVERVIEW 
 
Mitotic cell division can be divided into two basic categories: symmetric cell division and 
asymmetric cell division. Conventional cell division produces two identical daughter cells, 
whereas ACD results in daughter cells with differing fates (Figure 1.7). In ACD, the mother cell 
establishes an axis of polarity followed by unequal distribution of cell fate determinants, as well 
as unequal orientation of the mitotic spindle along the axis. This involves shifting their division  
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Figure 1.7. Symmetric versus asymmetric cell division. Symmetric divisions produce two 
identical daughter cells. Asymmetric cell division produces daughter cells with differing cell 
fates as a result of unequal distribution of fate determinants and resources. Red and green 
crescents represent different fate determinants (proteins and RNAs) that can be equally or 
unequally partitioned into daughter cells and may differentially influence the developmental 
potential of those cells. Adapted from Mapelli & Gonzalez 2012.  
 
 
 
 
 
 
 
 
 
	
	 	
	
	
	
	 	
	
	 	
	
	 	
	
	 	
	 		
		
	 	
		 Asymmetric	cell	division 
	 	 	 	 	 	Symmetric	cell	division 
			
27	
machinery toward a specific region of the cell cortex (Goldstein 2003). Finally, the cell will 
asymmetrically divide into two daughter cells (Gönczy 2008). ACD is used by many species to 
maintain stem cell populations, as well as during development to generate cellular diversity. 
ACD has been well studied in Drosophila melanogaster neuroblasts and Caenorhabditis elegans 
embryos, however ACD in mammalian systems remains poorly understood (Willard et al. 2004).  
 
Virtually all of the proteins involved in the process of ACD in lower metazoan models are 
evolutionary conserved in mammals (Johnston et al. 2009). D. melanogaster neuroblasts undergo 
asymmetric cell divisions to produce a large apical neuroblast and a smaller ganglion mother cell 
(GMC) (Willard et al. 2004). The apical determinants Bazooka (partitioning defective protein 3, 
PAR-3, in mammals), PAR-6, and aPKC form a protein complex that recruits the Inscuteable 
(Insc) protein to the apical cell cortex, directs spindle orientation, and helps segregate the basal 
determinants Numb, Miranda, and Prospero. Partner of Inscuteable (Pins, GPSM1 and GPSM2 
in mammals) is recruited by Insc to the apical cell cortex, where it then binds Gαi and Mud 
(nuclear mitotic apparatus protein, NuMA, in mammals) to form a ternary complex that directs 
spindle positioning and contributes to the generation of pulling forces on astral microtubules via 
the direct interaction between Mud and the minus-end-directed microtubule motor 
Dynein/Dynactin (Mapelli & Gonzalez 2012) (Figure 1.8). 
 
1.3.2 G PROTEINS AND THEIR ACCESSORY PROTEINS IN ASYMMETRIC CELL DIVISION 
 
G proteins are best known for their role in signal transduction downstream of seven 
transmembrane receptors, but they also play an essential role in the process of cell division. Gαi2  
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Figure 1.8. Positioning of the mitotic spindle by GPSM2. The ternary complex (Gαi-GPSM2-
NuMA), along with dynein/dynactin, positions the mitotic spindle poles in asymmetric cell 
division. 
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has been reported to bind to the kinetochores of chromatin during mitosis in 3T3 cells (Crouch & 
Simson 1997; Crouch et al. 2000). Gαo localizes to the mitotic spindle in a human carcinoma 
cell line and multiple animal cell lines, where it co-localizes with β-tubulin (Wu & Lin 1994). 
Furthermore, in bovine brain cells, Gβ subunits are incorporated into the mitotic spindle and 
interact with the mitotic spindle (Wu et al. 1998). 
 
In gpb-1 (the Gβ homologue) mutant C. elegans embryos, cell division axes are randomly 
orientated and centrosome positions are abnormal (Zwaal et al. 1996). Similar results were seen 
in neural progenitor cells in the developing mouse neocortex. When the carboxy-terminal region 
of β-adrenergic receptor kinase, which is known to sequester free Gβγ without affecting Gα 
signaling, was overexpressed, it led to a shift in spindle orientation. When GPSM1 was knocked 
down in neural progenitor cells via RNA interference (RNAi), alterations in spindle orientation 
similar to that seen with Gβ mutants or knockdowns was observed (Sanada & Tsai 2005). Gβ 
and GPSM1 appear to participate in the same processes.  	
Gα subunits and GPSM2/GPSM1 also appear to participate in similar cell division-related roles. 
In C. elegans embryos with RNAi directed against GOA-1 or GPA-16 (Gα homologues), 
centrosomes fail to separate properly and incorrect spindle orientations occur as a result of a lack 
of centrosome rotation, abnormal centrosome starting positions, and incorrect paths of 
centrosome migration (Gotta & Ahringer 2001; Miller & Rand 2000). Simultaneous inactivation 
of these Gα subunits results in the almost complete loss of spindle pulling forces from both the 
anterior and posterior poles of the dividing cell (Hampoelz & Knoblich 2004). It also results in 
the mitotic spindle being centrally instead of asymmetrically located, leading to an equal first 
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cleavage rather than the cleavage plane being asymmetrically displaced toward the posterior. 
RNAi targeted to GPR-1 and GPR-2, which replace the function of GPSM1 and GPSM2 in C. 
elegans, produced similar results (Schneider & Bowerman 2003a; Srinivasan et al. 2003). When 
GPB-1 is also inactivated, the result is the same, implying that this is due to the loss of Gα 
subunit function and not constitutive activation of Gβγ (Gotta & Ahringer 2001). Overexpression 
of Gαi1 in Madin-Darby canine kidney (MDCK) cells, but not Gαs, causes pronounced 
oscillations and rotations of the mitotic spindle indicative of strong pulling forces exerted on its 
astral microtubules. An identical phenotype is observed with the overexpression of GPSM2 (Du 
& Macara 2004).  
 
Numerous studies have implied that the coupling between GPSM motif-containing proteins and 
G proteins is important for the proper functioning of the latter during cell division. Gαi proteins 
and GPSM motif-containing proteins share similar subcellular localization during mitosis, and 
the interaction between GPSM domains and G proteins influences the subcellular localization of 
GPSM motif-containing proteins during both interphase and mitosis (Cho & Kehrl 2007; Shu et 
al. 2007). Blocking this interaction leads to abnormal exaggerated mitotic spindle rocking in 
kidney epithelial cells and cytokinesis defects (Willard et al. 2008; Cho & Kehrl 2007).  
 
The most thoroughly studied GPSM motif-containing protein in the context of cell division is 
GPSM2. The expression levels of GPSM2 have been observed to increase during metaphase in 
mammalian cell division. Furthermore, subcellular localization studies indicate that GPSM2 is 
important for the cortical positioning of the spindle pole, which likely reflects stronger pulling or 
pushing forces on the spindle pole (Blumer et al. 2006). Immunocytochemical staining shows 
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GPSM2 at the spindle in cells at metaphase, and at the midzone and midbody in cytokinetic cells 
(Fukukawa et al. 2010a). A similar pattern of upregulation during mitosis and localization to the 
midbody of cytokinetic cells has been reported for Ric-8A (Boularan et al. 2014). GPSM2 
transcript levels are upregulated in a large proportion of breast cancers, and treatment of those 
cells with siRNA targeting GPSM2 resulted in incomplete cell division and significant growth 
suppression in breast cancer cells (Fukukawa et al. 2010a).  
 
In its inactive form, the N-terminus and C-terminus of GPSM2 interact with one another, 
precluding the GPSM motifs from interacting with Gαi. However, fluorescent resonance energy 
transfer (FRET) studies demonstrate that when it binds the nuclear mitotic apparatus protein 
(NuMA), the intramolecular association between the two termini is released and GPSM2 can 
bind Gαi (Du & Macara 2004). This anchors the complex to the cell cortex, and the association 
between NuMA and the dynein/dynactin structure accounts for this complex’s ability to interact 
with microtubules. The motor activity of dynein/dynactin pulls the mitotic spindle to the cell 
cortex, thus forming the spindle poles (Merdes et al. 2000) (Figure 1.8). 
 
Precise mitotic spindle orientation is thought to be achieved through cycles of astral microtubule 
stabilization and destabilization (Dave et al. 2009). Gαi acts not only as a membrane tether but 
also as a switch, allowing ratcheting of pulling forces by rapid cycling of nucleotide exchange 
which causes temporary release between components of the Gαi-GPSM2-NuMA complex (Tall 
& Gilman 2005). This rapid cycling is accomplished by GAP and GEF activity of accessory 
proteins. In C. elegans, RGS7 and Ric-8A fulfill these roles, respectively (Dave et al. 2009). 
RGS14, which contains both a GPSM motif and an RGS domain, could in theory act as a GAP in 
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addition to binding Gαi making it as attractive candidate for participation in mitotic spindle 
orientation (Shu et al. 2007; Cho et al. 2005). GPSM3, which displays GEF activity and an 
ability to act as a GDI and bind Gαi, is another attractive prospect for a role in cell division.  
 
1.4 G PROTEIN SIGNALING MODULATOR 3 (GPSM3) 
1.4.1 IDENTIFICATION AND CHARACTERIZATION OF GPSM3 
 
GPSM3 is a 160 amino acid protein encoded by a gene within the major histocompatibility 
complex class III region of chromosome 6 (Cao et al. 2004; Zhao et al. 2010) (Figure 1.9). 
GPSM3 was first discovered in a yeast-based functional screen for activators of the pheromone 
response pathway in the absence of a GPCR. The yeast-based system was used to screen a 
human prostate leiomyosarcoma cDNA library, and one of the cDNAs isolated in the screen was 
GPSM3 (Cao et al. 2004). It contains three GPSM motifs at its C-terminus (conflicting reports 
exist regarding the activity of the second GPSM motif), while its short N-terminus contains 
multiple proline residues (14 out of 60 amino acids in total) (Kimple et al. 2004; Oner, Maher, et 
al. 2010; Zhao et al. 2010). Two different protein isoforms of GPSM3, with different N-terminal 
polypeptide sequences, have been predicted in the human genomic sequence database curated by 
Ensembl (Billard et al. 2014). The consensus among a number of studies is that GPSM3 is 
localized to the cytoplasm in cells, with it sometimes being seen in the nucleus and other times 
enriched at the plasma membrane (Cao et al. 2004; Giguère, Laroche, Oestreich, Duncan, et al. 
2012; Giguère, Laroche, Oestreich & Siderovski 2012; Zhao & Chidiac 2015). Studies show that 
GPSM3 mRNA is detectable in a variety of tissues such as the heart, placenta, lung, liver, brain, 
and spleen (Cao et al. 2004; Zhao et al. 2010). However, the public GeneAtlas database of the  
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Figure 1.9. Amino acid sequence of GPSM3. The three GPSM motifs are highlighted in 
green. The proline-rich N-terminal region is highlighted in red.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
1					MEAERPQEEEDGEQGPPQDEEGWPPPNSTTRPWRSA	37			PPSPPPPGTRHTALGPRSASLLSLQTELLLDLVAEAQSR	76			RLEEQRATFYTPQNPSSLAPAPLRPLEDREQLYSTILSH	116	QCQRMEAQRSEPPLPPGGQELLELLLRVQGGGRMEE	153	QRSRPPTHTC 
2
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human transcriptome shows that expression is restricted to hematopoietic cells with the highest 
signal strength in whole blood and CD14+ monocytes (Giguère et al. 2013). GPSM3 expression 
is also seen in rat epithelial cells and vascular smooth muscle cells (Zhao & Chidiac 2015). 
 
The list of protein-protein interactions that GPSM3 participates in has grown steadily in the 
literature over the past few years, with many partners being associated with G protein signaling 
(Table 1.2). GPSM3 has been shown to bind members of the Gαi/o family, coupling with Gαo 
and all three isoforms of Gαi (Cao et al. 2004). It shows a strong preference for Gαi over Gαo. 
GPSM3 does not interact with Gαs, Gαq, or Gα16. A study has shown that GPSM3 also 
associates with the first four isoforms of Gβ, however it apparently does not interact with Gβγ 
(Giguère, Laroche, Oestreich & Siderovski 2012; Cao et al. 2004). RGS5 has been identified as 
an interaction partner of GPSM3 (Zhao & Chidiac 2015), and BRET signals between GPSM3 
and the α2 adrenergic receptor have been observed as well (Oner, Maher, et al. 2010). GPSM3 
appears to form a complex with NOD-like receptor family, pyrin domain containing 3 protein 
(NLRP3) and the heat shock A8 protein (HSPA8) (Giguère et al. 2014). The 14-3-3 family of 
proteins stabilize GPSM3, and up to 25 potentially regulatory phosphorylation sites have been 
identified in GPSM3 (Giguère, Laroche, Oestreich, Duncan, et al. 2012; Bian et al. 2014).  
 
1.4.2 FUNCTIONAL ROLES OF GPSM3 
 
GPSM3 was discovered in a yeast-based screen that required Gβγ activation to single out 
activating proteins, and the GPSM motif is capable of promoting the dissociation of heterotrimer 
subunits (Cao et al. 2004; Ghosh et al. 2003). This would be expected to lead to the activation of 
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Table 1.2. GPSM3 protein-protein interaction partners.  
Protein 
 
Reference 
 
Confirmed via interaction study 
 
Gαi1-3 
 
(Cao et al. 2004; Zhao et al. 2010) 
 
Gαo 
 
(Cao et al. 2004; Zhao et al. 2010) 
 
Gβ1-4 
 
(Giguère, Laroche, Oestreich & Siderovski 
2012) 
 
14-3-3 family members 
 
(Giguère, Laroche, Oestreich, Duncan, et al. 
2012) 
 
NOD-like receptor family, pyrin 
domain containing 3 protein (NLRP3) 
 
(Giguère et al. 2014) 
 
Heat shock protein A8 (HSPA8) 
 
(Giguère et al. 2014) 
 
α2 adrenergic receptor 
 
(Oner, Maher, et al. 2010) 
 
RGS5 
 
(Zhao & Chidiac 2015) 
 
Experimental evidence 
 
Fibroblast growth factor 3 (FGFR3) 
 
(Lehner et al. 2004) 
 
Supervillin (SVIL) 
 
(Nebl et al. 2002) 
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PLCβ, however one study showed that overexpression of GPSM3 fails to appreciably increase 
inositol phosphate levels and another showed that it in fact resulted in a decrease in inositol 
phosphate levels by greater than 50% (Cao et al. 2004; Giguère, Laroche, Oestreich & 
Siderovski 2012). This suggests that GPSM3 does not promote Gβγ-mediated cell signaling via 
the promotion of heterotrimer dissociation. When expressed in the presence of membrane-
tethered or GPCR-tethered Gαi1/2, GPSM3 is apparently redistributed to the plasma membrane 
(Willard et al. 2008; Robichaux et al. 2015; Oner, Maher, et al. 2010). Gαi/o mutants incapable 
of binding to GPSM motifs did not exhibit this effect (Willard et al. 2008). Agonist activation of 
the α2A adrenergic receptor leads to decreased BRET signals between Gαi2 and GPSM3. This 
suggests that seven transmembrane receptors can bind Gαi-GPSM3 complexes and that receptor 
activation leads to reversible dissociation between GPSM3 and Gαi in a cycle analogous to that 
seen with receptor and Gαβγ (Robichaux et al. 2015). GPSM3 also appears to be regulated by the 
non-receptor GEFs, with the interaction between GPSM3 and Gαi1 being regulated in a biphasic 
manner by Ric-8A depending on its level of expression. However, the increasing BRET signal at 
high Ric-8A concentrations is likely due to the observation that Ric-8A increases Gαi1 
expression levels (Oner et al. 2013).  
 
As expected, GPSM3 demonstrates G protein regulatory effects on Gα subunits. The three 
GPSM motifs in its C-terminal region display GDI activity for Gαi/o subunits (Cao et al. 2004; 
Zhao et al. 2010; Oner, Maher, et al. 2010). Whether all three of these GPSM motifs can bind 
Gαi/o subunits at the same time remains to be seen, however reports on GPSM motifs suggest 
that additional motifs may act as competitive decoys in order to create one ultrasensitive 
functional motif (Lu et al. 2012; Smith & Prehoda 2011). The proline-rich N-terminal domain of 
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GPSM3 exhibits the unique ability to differentially affect the nucleotide state of different Gα 
subunits, which is not surprising since repetitive proline-rich sequences are often found to be 
docking sites for signaling modules (Zhao et al. 2010; Cao et al. 2004). The N-terminal region of 
GPSM3 displays weak GDI effects on Gαo, but interestingly it exhibits GEF activity on Gαi1 
(Zhao et al. 2010). It has also been shown that GPSM3 enhances the GAP activity of RGS5 by 
binding to it, and that this binding in turn impedes the inhibitory effect of GPSM3 on GTP 
turnover (Zhao & Chidiac 2015). GPSM3 may also regulate the stability of Gβ subunits before 
they become complexed with Gγ (Giguère, Laroche, Oestreich & Siderovski 2012). 
 
1.4.3 GPSM3 DISEASE ASSOCIATION 
 
GPSM3 has been linked to a large number and variety of diseases. Significant increases in the 
expression of GPSM3 are observed in a rat model for polycystic kidney disease compared to the 
non-cystic controls (Lenarczyk et al. 2015). In prostate cancer models which mimic 
angiogenesis, GPSM3 expression increases by greater than two-fold relative to controls, and it 
has been identified as a gene required for the proliferation of p53 human cancer cell lines (Lapan 
et al. 2009; Xie et al. 2012). Expression changes in GPSM3 have also been connected to cell 
culture adaptation (Tompkins et al. 2012). GPSM3 polymorphisms are associated with childhood 
obesity in Hispanic populations and atopic dermatitis (Comuzzie et al. 2012; Chang et al. 2012). 
The connection between GPSM3 and autoimmune disease has been well established, with links 
to ulcerative colitis, systemic lupus, rheumatoid arthritis, and ankylosing spondylitis (Pathan et 
al. 2009; Barcellos et al. 2009; Giguère et al. 2013).   
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The first connection between GPSM3 and arthritis was discovered when polymorphisms within 
the human GPSM3 gene locus were identified as being significantly less prevalent in multiple 
autoimmune diseases (Sirota et al. 2009; Corona et al. 2010). These protective genetic variants 
have been found to result in a decrease in GPSM3 transcript abundance in individuals 
homozygous for the single nucleotide polymorphisms (Gall, Wilson, et al. 2016). The effects of 
GPSM3 on myeloid-dependent autoimmune disease have been studied in a GPSM3-/- mouse 
model in which collagen antibody-induced arthritis (CAIA) was induced (Giguère et al. 2013). 
Mice lacking GPSM3 were protected from CAIA, showing significant decreases in paw swelling 
and clinical disease scores, as well as a reduction in inflammation and cartilage erosion 
compared to controls. Furthermore, monocyte-representative pro-inflammatory cytokines and 
chemokine receptors were decreased in GPSM3-/- mouse paws, and GPSM3-deficient myeloid 
cells had reduced migration.  
 
GPSM3 mRNA and protein levels are both seen to decrease when the monocytic THP-1 cell line 
is differentiated into macrophage-like cells, suggesting a role in both differentiation and 
migration of monocytes. Knockdown of GPSM3 in this cell line disrupts ex vivo migration 
towards certain chemokines (Gall, Wilson, et al. 2016). In the human promyelocytic leukemia 
NB4 cell line, GPSM3 transcript and protein levels increase in response to retinoic acid-induced 
differentiation into a model of neutrophil physiology (NB4*). Reducing GPSM3 expression in 
NB4* cells using siRNA disrupts chemotaxis towards chemoattractants involved in neutrophil 
recruitment to the arthritic joint (Gall, Schroer, et al. 2016). Interleukin-1β, triggered by NLRP3-
dependent inflammasome activators, is negatively regulated by GPSM3 (Giguère et al. 2014). 
GPSM3-null mice have enhanced serum and peritoneal interleukin-1β production following 
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intraperitoneal aluminum hydroxide injection, and bone marrow-derived macrophages lacking 
GPSM3 expression show a significant increase in NLRP3-dependent IL-1β secretion (Giguère et 
al. 2014).  
 
1.4.4 GPSM3 IN VASCULAR SMOOTH MUSCLE CELLS 
 
Vascular smooth muscle cells (VSMCs) typically have a contractile phenotype that allows the 
smooth muscle comprised of them to expand and contract, thereby controlling the diameter of 
the vasculature. However, the transition of VSMCs from a contractile to a migratory, 
proliferative phenotype is known to underlie cardiovascular disease and also occurs in response 
to isolation and culturing (Sandison et al. 2016; Dzau et al. 2002; Fingerle et al. 1989). Other 
GPSM motif-containing proteins such as GPSM2 and GPSM1 have been implicated in both cell 
migration (Taymans et al. 2006; Kamakura et al. 2013) and proliferation, while GPSM3 has 
previously been linked with cell migration (Giguère et al. 2013; Gall et al. 2016). Therefore, 
vascular smooth muscle cells, which are known to express GPSM3, are an excellent model to 
study a potential role for GPSM3 in cell division (Zhao & Chidiac 2015). In this study, VSMCs, 
in addition to other tissues, were obtained from Wistar-Kyoto rats (WKY) and spontaneously 
hypertensive rats (SHR). SHR rats display significantly higher blood pressure than their WKY 
counterparts (approximately 193 mmHg compared to approximately 133 mmHg) (Leung et al. 
2016). In addition to elevated blood pressure, these rats have many other differences with 
normotensive WKY rats including increased Gαi-mediated pathway activity likely contributing 
to hypertension, increased innervation in the spleen and thymus, and increased inflammation of 
the liver, heart, kidney, and brain (Kost et al. 1999; Purcell & Gattone 1992; Sun et al. 2006). 
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SHR vascular smooth muscle cells have been shown to divide at a rate 1.75 times that of WKY 
VSMCs (Hadrava et al. 1991). This increased proliferation rate could be linked to the 
hypertensive phenotype in SHR rats as division of VSMCs could increase blood vessel wall 
thickness and in the process decrease the diameter of the vessel. Additionally, a difference in 
GPSM3 protein expression in VSMCs was seen in our lab, with VSMCs derived from SHR rats 
exhibiting greater expression than WKY-derived VSMCs (Zhao 2011). Elevated expression of 
GPSM3 could be linked to the increased rate of proliferation in VSMCs and the hypertensive 
phenotype of SHR rats.   
 
1.5 RESEARCH PURPOSE AND AIMS 
 
The fundamental participants of GPCR-mediated cell signaling were originally recognized to be 
the receptors, heterotrimeric G proteins, and effectors. However, over time, studies have begun 
to reveal that signaling processes are not as simple as once imagined. Accessory proteins such as 
GPSM3 fine-tune signals by influencing the nucleotide-state of the Gα subunit, and may 
participate in non-canonical G protein signaling via alternative complexes. They also perform 
other cellular functions, such as their role in asymmetric cell division. However, GPSM3 has not 
been linked to cell division in the literature at this time. The purpose of this study is to 
investigate whether or not GPSM3 plays such a role. I hypothesize that G protein signaling 
modulator 3 plays a role in cell division of mammalian cells, likely via an interaction with the 
mitotic spindle. This role in mammalian cells is investigated in a vascular smooth muscle cell 
model system. The specific aims of this study are: 
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1. To investigate the difference in GPSM3 transcript and protein levels between 
normotensive Wistar-Kyoto rats and spontaneously hypertensive rats. 
2. To investigate whether GPSM3 expression is linked to the rate of cell division. 
3. To investigate potential mechanisms of action for GPSM3 in the process of cell 
division via its interaction with other proteins and its localization during mitosis.  
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2 METHODS 
2.1 TISSUE SAMPLE COLLECTION 
 
Dr. Robert Gross performed all tissue sample collection. All animal work was carried out in 
accordance with official guidelines. Four male Wistar-Kyoto (WKY) and four male 
spontaneously hypertensive (SHR) rats (Harlan Laboratories, Indianapolis, IL) were sacrificed at 
10 weeks of age, after the onset of hypertension in the SHR rats. Rats were anaesthetized with 
3% isofluorane gas, then sacrificed by cardiac puncture and whole blood was collected. Tissue 
samples from the aorta, heart, liver, lung, and spleen were collected. Leukocytes were isolated 
from heparin-treated whole blood using a ficoll-hypaque solution and differential centrifugation 
according to the method of Böyum 1968. All samples were stored at –80˚C.  
 
2.2 AORTIC VASCULAR SMOOTH MUSCLE CELL ISOLATION 
 
Vascular smooth muscle cells (VSMCs) were kindly provided by Dr. Robert Gros. All animal 
work was carried out in accordance with official guidelines. A modified version of the protocol 
from Cornwell & Lincoln 1989 was used to isolate the VSMCs. Male WKY and SHR rats at 10 
weeks of age were used, after the onset of hypertension in the SHR rats. Rat aortas were cleaned 
and cut longitudinally. Adipose tissue was removed via enzymatic digestion by placing aortas in 
1 ml of Ham’s F12 medium (ThermoFisher Scientific, Waltham, MA, with 1% gentamycin and 
10% fetal bovine serum, FBS) and 1 mg of collagenase per aorta and incubating for 20 minutes 
at 37°C. Medium was removed. 1 ml of Ham’s F12 medium and 1 mg of collagenase per aorta 
were added and sample was incubated for 30 minutes at 37°C, followed by removal of the 
medium and a further, identical incubation in fresh medium supplemented with collagenase. 
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Samples were centrifuged for 5 minutes at 200 x g at room temperature. The supernatant was 
then discarded. The pellet was resuspended in 1 ml of Ham’s F12 medium, and 1 mg 
collagenase, and 0.5 mg elastase per aorta and incubated for 90 minutes at 37°C. Sample was 
collected by pipette and filtered using a Nitex 100 µm cell strainer to dissociate clumps into a 
uniform single-cell suspension. 10 ml Dulbecco’s Modified Eagle Medium (DMEM, Gibco Life 
Technologies, Carlsbad, CA) (with 10% FBS) was then added to the filtrate. The cell suspension 
was then centrifuged for 5 minutes at 200 x g at room temperature. Supernatant was collected 
and discarded. Cells were resuspended in 10 ml DMEM (with 10% FBS and 10% 
fungizone/gentamicin), and then plated in a 10 cm cell culture dish.  
 
2.3 SERUM STARVATION AND REPLACEMENT 
2.3.1 SERUM STARVATION AND REPLACEMENT PRIOR TO RNA AND PROTEIN 
EXTRACTION 
 
WKY and SHR vascular smooth muscle cells were grown in DMEM (with 10% FBS) at 37˚C. 
When cells were 60% confluent, medium was removed and cells were washed in 1X sterile 
phosphate-buffered saline (PBS, Fisher Scientific) (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, pH 7.4). DMEM (with 0% FBS) was then added and cells were incubated for 48 hours 
at 37˚C. Medium was then removed, cells were washed in sterile PBS again, and DMEM (with 
10% FBS) was added. Cells were grown for an additional 48 hours at 37˚C. Cells were collected 
and processed for either RNA extraction or protein extraction at 24 hour intervals during the 
course of the experiment.  
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2.3.2 SERUM STARVATION AND REPLACEMENT PRIOR TO IMMUNOFLUORESCENT 
LABELING 
 
WKY and SHR vascular smooth muscle cells were grown in DMEM (with 10% FBS) at 37˚C. 
When cells were 40% confluent, medium was removed and cells were washed in sterile 
phosphate buffered saline (PBS). DMEM (with 0% FBS) was then added and cells were 
incubated for 24 hours at 37˚C. Medium was then removed, cells were washed in sterile PBS 
again, and DMEM (with 10% FBS) was added. SHR VSMCS were grown for an additional 12 
hours at 37˚C while WKY VSMCs were grown for an additional 20 hours at 37˚C. Cells were 
then prepared for immunofluorescent labeling and imaging.   
 
2.4 RNA EXTRACTION 
 
Total RNA was extracted from both cell culture and homogenized tissue samples using TRIzol 
reagent (Invitrogen, Carlsbad, CA). Samples were incubated in TRIzol reagent at room 
temperature for 5 minutes. 200 µl of chloroform per 1 ml of TRIzol reagent was added and 
samples were vortexed for 15 seconds. Samples were incubated at room temperature for 3 min, 
following which they were centrifuged at 4˚C for 15 minutes at 5300 x g. The aqueous phase was 
extracted, and 500 µl of isopropanol per 1 ml TRIzol reagent used was added to precipitate RNA. 
Samples were incubated at room temperature for 10 minutes, and then centrifuged at 4˚C at 5300 
x g for 20 minutes. Supernatant was removed and pellets were superficially washed with 1 ml 
75% ethanol per 1 ml TRIzol reagent used. Samples were centrifuged at 4˚C at 5300 x g for 10 
minutes. The supernatant was removed, and pellets allowed to air dry. Dry pellets were stored at 
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–80˚C, and later suspended in DEPC water (Life Technologies) and diluted to 0.05 µg/µl. RNA 
purity and concentrations were quantified through spectrophotometry (NanoDrop Lite, Thermo 
Scientific). RNA samples with an absorbance ratio (A260 nm / A280 nm) of 1.8-2.2 were determined 
to be sufficiently pure for use in PCR applications.  
 
2.5 REVERSE TRANSCRIPTION (RT-PCR) AND QUANTITATIVE POLYMERASE CHAIN 
REACTION (QPCR) 
 
RNA samples (2 µg) were reverse transcribed (RT-PCR) to generate first strand cDNA using a 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) on a T100 Thermo Cycler 
(BioRad). Primer sets directed against target genes of interest were designed using the National 
Centre for Biotechnology Information Nucleotide sequences database 
(www.ncbi.nlm.gov/nuccore) and Invitrogen’s OligoPerfect Designer primer designing tool 
(www.thermofisher.com/oligoperfect/). Primers were custom manufactured by and purchased 
from Sigma-Aldrich (St. Louis, MO) Custom DNA Oligos (Table 2.1). mRNA expression levels 
of GPSM3 were determined through qPCR carried out in 384 well plates using fluorescent 
nucleic acid dye SensiFAST SYBR Green No-ROX kit (Bioline) based assays, following the 
manufacturer’s protocol. Reactions were carried out on CFX384 Real Time PCR Detection 
System and analyzed using a CFX Manager 3.0 program (BioRad). The cycle threshold was set 
so that exponential increases in amplification were approximately level between all samples at 
the linear phase of the amplification curves. Relative mRNA levels of rGPSM3 were generated 
from five-fold serial dilutions of pooled cDNA samples, and then normalized to a reference gene 
(GAPDH in tissue samples and β2-microglobulin in VSMC primary culture samples). Reference  
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Table 2.1. Primers for qPCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target gene Forward Primer Reverse Primer 
GPSM3 5’-CCTTCTCTCTGGGACTCAAA-3’ 5’- AGCCCTCACAACCTGTTTAG-3’ 
GAPDH 5’-AACTTTGTGAAGCTCATTTCCT-3’  
5’-ATTGATGGTATTCGAGAGAAGG-3’ 
 
B2M (β2-
microglobulin) 5’- ACGTTTGTCTTGGTGATGTG-3’ 5’-CAGTAGTCCCTGATGCTCCT-3’ 
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genes were stable across all samples and conditions to allow comparative assessments on the 
relative change in the expression of GPSM3.  
 
2.6 PROTEIN ISOLATION 
 
Cell lysates were prepared by washing twice with ice-cold 1X phosphate-buffered saline (PBS, 
Fisher Scientific) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, pH 7.4) and scraped into 150 
µl of ice-cold lysis buffer (250 mM NaCl, 50 mM Tris pH 8, 5 mM EDTA, 0.5% Triton X-100 
(IGEPAL), phenylmethylsulfonyl fluoride protease inhibitor tablet (Roche, 04693116001), 20 
mM Na4P2O7, 10 mM NaF, and 20 mM Na3VO4). Cell lysates were homogenized by vigorous 
pipetting and underwent three consecutive freeze-thaw cycles via flash freezing with liquid 
nitrogen. Pellets were sedimented by centrifugation at 11,000 x g for 15 minutes at 4ºC. 
Supernatants were collected and protein concentrations were determined using a Bicinchoninic 
Acid Protein Assay Kit (Sigma, BCA1) and a VICTOR3V Microplate Reader (PerkinElmer, 
1420-251).  
 
2.7 IMMUNOBLOTTING 
 
Protein samples were prepared in 5X Laemmli loading (sample) buffer (60 mM Tris-HCl pH 6.8, 
2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.02% bromophenol blue) and balanced with 1X 
sample buffer for equal protein concentration. Samples were heated at 99ºC for 5 minutes prior 
to gel loading and gel electrophoresis in order to denature the proteins. Equal amounts of protein 
(30 µg) were separated by 15% SDS-PAGE and wet transferred onto nitrocellulose membrane 
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(Whatman Protran). Membranes were incubated for 1 hour in blocking buffer (Tris-buffered 
saline, 0.1% Tween 20, 5% skim milk) and rocked at room temperature before overnight 
incubation at 4ºC, rocking with either: anti-GPSM3 (1:500, GeneScript custom ordered, 
described in Zhao & Chidiac 2015) or anti-β tubulin for protein loading control (1:1000, Pierce 
PA5-16863). Following overnight incubation, membranes were washed 4 times for 5 min with 
TBST (Tris-buffered saline, 0.1% Tween 20) and incubated for 1 h at room temperature with 
horseradish peroxidase-conjugated secondary antibodies: anti-rabbit IgG (1:4000, Pierce 31463). 
Immunoblots were then washed 4 times for 5 min with TBST. Immunoblots were visualized with 
SuperSignal West Pico chemiluminescent substrate (ThermoFisher Scientific, 34080) and 
digitally imaged using Bio-Rad VersaDoc camera and Quantity One program (Bio-Rad, model 
GS-700). Relative protein expression levels from immunoblots were quantified and analyzed 
using densitometry software (Quantity One, Bio-Rad). Relative densitometric signal of protein 
bands were determined with subtraction of background signal of immunoblots, and GPSM3 
protein bands were then normalized to corresponding β-tubulin bands.  
 
2.8 TRANSFECTION  
 
All transfections were performed using the Human Embryonic Kidney 293 (HEK-293) cell line 
under standard conditions of 37ºC and 5% CO2, in DMEM with 10% FBS. HEK-293 cells are 
commonly used for in vitro experiments due to their ease of transient transfection (Li et al. 
2013). 
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2.8.1 TRANSFECTION FOR MTT ASSAY AND CELL COUNTING 
 
Plasmid constructs encoding EYFP (enhanced yellow fluorescent protein)-tagged GPSM3 were 
generously donated by Dr. Joe Blumer from the Medical University of South Carolina and are 
described in Oner et al. 2010.  To summarize the protocol, cells were seeded and grown to 70-
85% confluence in a 100 mm dish before transfection. Once 70-85% confluent, 400 ng of EYFP 
or EYFP-GPSM3 DNA plasmid was diluted in 450 µl of sterilized water in a sterile tube. 50 µl 
of 2.5 M CaCl2 was added to the diluted DNA, followed by 500 µl of 2x HEPES-buffered saline 
(HBS) solution (0.28 M NaCl, 0.05 M HEPES, 1.5 mM Na2HPO4, pH 7.0) that was slowly 
dripped over the DNA/CaCl2 solution and then mixed immediately. The mixture was then slowly 
dripped over the cells which were incubated for ~18 hours with the transfection reagents. 
Following incubation, cells were washed with 1x PBS three times and fresh DMEM with 10% 
FBS was added. Cells were allowed to recover from transfection for 3-6 hours and then diluted 1 
in 12.5 in addition fresh DMEM with 10% FBS. Cells were then reseeded in 24-well plates with 
500 µl per well.  
 
2.8.2 TRANSFECTION FOR MAMMALIAN TWO-HYBRID ASSAY 
 
Transfections were performed using Lipofectamine 2000 (Life Technologies, 11668-019) 
according to the manufacturer’s protocol. To summarize the protocol, cells were seeded and 
grown to 70% confluence before transfection. Once 70% confluent, 10 µl of Lipofectamine 2000 
reagent was diluted into 250 µl of Opti-MEM® I Reduced Serum Medium (Life Technologies, 
31985-070) in an Eppendorf tube. In a separate eppendorf tube, 1 µg of each plasmid DNA to be 
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transfected was diluted in 250 µl of Opti-MEM® I Reduced Serum Medium and both eppendorf 
tubes were incubated at room temperature for 5 minutes. The contents of the eppendorf tubes 
were thoroughly mixed together and were incubated at room temperature for 20 minutes. The 
combined mixture was added to the cells and the cells were plated in a 96-well clear bottom 
white assay plate. The mixture was allowed to incorporate into the cells for 24 hours. 
 
2.9 MTT ASSAY 
 
An MTT assay measures time-related changes in the metabolic activity of cells via their ability 
to reduce MTT reagent (tetrazolium salts) into formazan crystals. The purple formazan crystals 
can then be solubilized in DMSO and quantified by spectrophotometry. This can be used as a 
proxy for measuring the proliferation rate of cells. Transfected cells were subjected to an MTT 
assay on each of the five days of the experiment in order to assess changes in cell population, 
with the first day being marked as day 0. Separate wells were used for each day as MTT reagent 
is cytotoxic and the cells can be damaged and even killed during the course of the MTT assay 
(Riss 2006). A nonlinear regression was performed on both data sets using a exponential plateau 
model with the equation Y = Y0 + (Ymax – Y0)*(1 – e^(-k*x)), where Y0 is the Y-intercept, Ymax 
is the plateau value, e is Euler’s number, k is the growth rate constant measured in reciprocal 
units to those x is measured in (days-1), x is time in days, and Y is the absorbance value 
representing cell population size. Doubling time (DT) can then be calculated as DT = ln2 / k.  
 
50 µl of 2.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT reagent, 
Sigma M2128) was added to each well in a 24-well plate and incubated at 37°C for 2 hours. 
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Following incubation, medium was slowly aspirated so as to not disrupt the formazan crystals. 
500 µl of working grade dimethyl sulfoxide (DMSO) was added to each well and the plate was 
covered in aluminum foil. Plates were rocked for 2 hours and then absorbance was measured 
using a wavelength of 595 nm on a Thermo Multiskan Spectrum 1500 spectrophotometer 
(ThermoFisher Scientific, 51118750). Three control wells per plate containing only 500 µl of 
DMSO are also measured and the average value of these was subtracted from the experimental 
values.  
 
2.10 CELL COUNT ASSAY 
 
To ensure that the MTT data was indicative of an increased rate of proliferation and not 
increased cell size resulting in increased metabolism, cell counts were performed on cells 
expressing EYFP or EYFP-GPSM3. Five locations chosen at random within each well were 
imaged using an Olympus IX71 fluorescent microscope (Olympus Canada) and the number of 
cells expressing EYFP or EYFP-GPSM3 was analyzed using ImageJ software. 
 
2.11 IMMUNOFLUORESCENT LABELING 
 
Adherent cells were washed once in 1 ml 37°C PBS. Cells are then fixed by incubation in 1 ml 
4% formaldehyde for 10 minutes at room temperature and then washed five times with 1 ml 
room temperature PBS. Cells were then incubated in 1 ml 0.25% triton X-100 (in PBS) for 5 
minutes at room temperature and then washed five times with 1 ml room temperature PBS. Cells 
were incubated in 1 ml room temperature PBS containing 10% FBS for 1 hour. Next, cells were 
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incubated in 1 ml anti-GPSM3 primary antibody and anti-β-tubulin primary antibody (diluted 
1:500 in PBS) overnight at 4°C. Cells were then washed fives times with 1 ml room temperature 
PBS and then incubated in 1 ml AlexaFluor 488 goat anti-rabbit and AlexaFluor 568 goat anti-
mouse secondary antibodies (diluted 1:500 in PBS) for 1 hour at room temperature in the dark. 
Cells were then washed five times in 1 ml room temperature PBS. Cells are next incubated in 
250 µl DAPI (ThermoFisher Scientific, 62248) (diluted 1:1000 in PBS) for 5 minutes at room 
temperature and then washed three times with 1 ml room temperature PBS. Finally, cells are 
immunomounted by applying a small drop of medium to a glass slide and placing the cell-coated 
coverslip face down onto the droplet. The slide is stored in the dark for at least 2 hours until dry. 
Cells are then visualized on an Olympus FV1000 confocal microscope at the Robarts Research 
Institute’s Confocal Microscopy Core Facility. 10 µg/µl anti-GPSM3 primary antibody blocking 
peptide (GenScript) was added to the 1 ml PBS containing anti-GPSM3 primary antibody and 
anti-β-tubulin primary antibody (diluted 1:500) and incubated overnight at 4°C for the blocking 
peptide experiments. The blocking peptide sequence, EAERPQEEEDGEQC, corresponds to the 
first fourteen amino acids of GPSM3 following the initial methionine.  
 
2.12 MAMMALIAN TWO-HYBRID SYSTEM 
 
The CheckmateTM Mammalian Two-Hybrid System (Promega, E2440) enables in vivo detection 
of protein-protein interactions. This is accomplished using three vectors: pACT, pBIND, and 
pG5luc (Figure 2.1). Both the pACT and pBIND vectors utilize a human cytomegalovirus 
(CMV) immediate early promoter to drive expression. In addition, the pBIND vector expresses 
the Renilla reniformis luciferase under the control of the SV40 promoter, which allows for  
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Figure 2.1. CheckmateTM Mammalian Two-Hybrid System vectors. 
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normalization of differences in transfection efficiency. The pG5luc vector contains five GAL4 
binding sites upstream of a minimal TATA box, which in turn is upstream of the firefly 
luciferase gene. Subcloning a target gene into the pACT vector and subsequent expression results 
in the protein of interest with a C-terminally attached transcriptional activation domain. 
Subcloning a target gene into the pBIND vector and subsequent expression results in the protein 
of interest with a C-terminally attached DNA-binding domain. When a gene of interest with an 
attached transcriptional activation domain interacts with a second gene of interest with an 
attached DNA-binding domain, these two attached domains become closely associated. This 
results in the promotion of the assembly of RNA polymerase II complexes at the TATA box of 
the pG5luc vector, which increases transcription of the firefly luciferase reporter gene. Each gene 
of interest is subcloned into both the pACT and pBIND vectors. This is done to overcome the 
phenomenon of vector directionality, which is the apparent difference in strength of observed 
interactions depending on the vector context of each insert. Therefore, each protein-protein 
interaction is tested with both possible fusion protein interactions. The kit also provides positive 
control vectors: pACT-MyoD and pBIND-Id. A negative control consists of pACT and pBIND 
without inserts. See Table 2.2 for a list of genes of interest. 
 
2.13 DNA CONSTRUCTS 
 
Plasmids encoding the genes of interest were subjected to PCR using Platinum® Pfx DNA 
polymerase (ThermoFisher Scientific, 11708021) as per the manufacturer’s instructions and 
primers (Table 2.3) designed to introduce highly specific nucleotide sequences (restriction sites) 
on either side of the gene. PCR products were run on a 1% agarose gel (0.011 g/ml UltraPureTM 
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Agarose (Invitrogen), 40 mM Tris-acetate, 1 mM EDTA, 0.02 µl/ml ethidium bromide, pH 8.3) 
for 45-120 minutes at 100-150 V. DNA bands were viewed on gel under UV light, excised, and 
then purified using a Gel/PCR DNA Extraction Kit (FroggaBio, Toronto, ON, DF100) as per the 
manufacturer’s instructions. Genes of interest that were considered too long for the PCR method 
to be reliable were altered using gBlocksTM designed by Dr. Alexey Pereverzev to have the 
necessary restriction sites (synthesized using the Gibson Assembly™ method based on the 
technique described by Gibson et al. 2009). Plasmids encoding both the genes of interest as well 
as the parent vectors were then digested with the appropriate restriction enzymes (Table 2.2) as 
per the manufacturer’s instructions. The digested fragments of DNA were separated on 1% 
agarose gel (0.011 g/ml UltraPureTM Agarose (Invitrogen), 40 mM Tris-acetate, 1 mM EDTA, 
0.02 µl/ml ethidium bromide, pH 8.3) for 45-120 minutes at 100-150 V. DNA bands were 
viewed on gel under UV light, excised, and then purified using a GenepHlowTM Gel/PCR Kit 
(FroggaBio, DFH100) as per the manufacturer’s instructions. Each digested gene of interest was 
then ligated into both parent vectors using T4 DNA Ligase (Promega, M1801). The products of 
these ligations were then transformed into Subcloning EfficiencyTM DH5αTM Competent Cells 
(ThermoFisher Scientific, 18265017) as per manufacturer’s instructions and plated on an agar 
plate containing 100 µg/ml ampicillin and incubated overnight at 37°C. Bacterial colonies were 
chosen and grown in selective medium overnight at 37°C and at 225 RPM. Plasmid was then 
purified using PrestoTM Mini Plasmid Kit (FroggaBio, PDH300) as per manufacturer’s 
instructions. The Robarts Research Institute DNA Sequencing Facility (London, ON) confirmed 
all DNA sequences via fluorescent DNA sequencing. 
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Table 2.2. Genes of interest and the restriction enzymes used for subcloning. 
 
Gene Company (plasmid) Restriction enzymes 
GPSM3 Kindly provided by Dr. David P. Siderovski, Department of 
Physiology and 
Pharmacology, West Virginia 
University School of 
Medicine, Morgantown, WV, 
USA 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GPSM3-mGL SalI (Invitrogen, 15217-029), XbaI (Fermentas, FD0684) 
GNAI1 (Gαi1) cDNA Resource Center, GNAI10EI00 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GNAI2 (Gαi2) cDNA Resource Center, GNAI20EI00 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GNAS (Gαs) cDNA Resource Center, GNA0SSEI00 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GNAO (Gαo) cDNA Resource Center, GNA0OAEI00 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GNAO (Gαo-Q205L) cDNA Resource Center, GNA0OA00C0 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
GNB1 (Gβ1) cDNA Resource Center, GNB0100000 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
FGFR3 DNASU Plasmid Repository, HsCD00294949 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
SELPLG DNASU Plasmid Repository, HsCD00041063 
SalI (Invitrogen, 15217-029), 
XbaI (Fermentas, FD0684) 
NUMA1 (NuMA) Addgene, Plasmid #28238 SalI (Invitrogen, 15217-029), MluI (Roche, 10663721) 
NIN (Ninein) DNASU Plasmid Repository, HsCD00516498 
KflI (ThermoFisher Scientific, 
FD2164), SpeI (NEB, 
R0133S), SalI (Invitrogen, 
15217-029), NotI (NEB, 
R0189S) 
SVIL (Supervillin) Addgene, Plasmid #13040 SalI (Invitrogen, 15217-029), MluI (Roche, 10663721) 
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Table 2.3. Primers for Mammalian Two-Hybrid experiments. 
 
 
 
 
 
 
 
 
 
 
Target Forward Primer Reverse Primer 
GPSM3, GPSM3-
mGL 
5’-ACGCGTCGACCCATGGAGGCT 
GAGAGACCCCAGGAAGAAGAG-3’ 
5’- GCTCTAGATCAGCAGGTGT 
GTGTGGGGGGCCGGGACCT-3’ 
GNAI1/2 (Gαi1, 
Gαi2) 
5’-ACGCGTCGACCCATGGGCTGC 
ACGCTGAGCGCCGAGGACAAG-3’ 
 
5’-CGAGGCTGATCAGCGGGTTTA 
AACGGGCCCTCTAGACTCGAG-3’ 
 
GNAS (Gαs) 5’- ACGCGTCGACCCATGGGCTGC CTCGGGAACAGTAAGACCGAG-3’ 
5’-CGAGGCTGATCAGCGGGTTTA 
AACGGGCCCTCTAGACTCGAG-3’ 
GNAO (Gαo, Gαo-
Q205L) 
5’-ACGCGTCGACCCATGGGATGT 
ACTCTGAGCGCAGAGGAGAGA-3’ 
 
5’-GCTCTAGATCAGTACAAG 
CCGCAGCCCCGGAGGTTGTT-3’ 
 
GNB1 (Gβ1) 
5’-ACGCGTCGACCCATGAGTGA 
GCTTGACCAGTTACGGCAGGAG-3’ 
 
5’-GCTCTAGATTAGTTCCAG 
ATCTTGAGGAAGCTATCCCA-3’ 
 
FGFR3 
5’-ACGCGTCGACCCATGGGCGCC 
CCTGCCTGCGCCCTCGCGCTC-3’ 
 
5’-GCTCTAGACTACGTCCGC 
GAGCCCCCACTGCTGGGTGG-3’ 
 
SELPLG 
5’-ACGCGTCGACCCATGCCTCT 
GCAACTCCTCCTGTTGCTGATC-3’ 
 
5’-GCTCTAGACTAAGGGAGG 
AAGCTGTGCAGGGTGAGGTC-3’ 
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2.14 LUCIFERASE ASSAY SYSTEM 
 
The Dual-Glo® Luciferase Assay System (Promega, E2920) was utilized to quantify luciferase 
reporter gene expression as a measure of the strength of tested protein-protein interactions, as per 
manufacturer’s instructions. Briefly, a volume of Dual-Glo® Reagent equal to the volume of 
culture medium in the well was added to each well, mixed, and allowed to sit for 10 minutes 
while cell lysis occurred. Firefly luciferase luminescence was then measured using a VICTOR3V 
Microplate Reader (PerkinElmer, 1420-251). To quench this reaction, a volume of Dual-Glo® 
Stop & Glo® Reagent equal to the original culture medium volume was then added to each well, 
mixed, and allowed to incubate for 10 minutes at room temperature. Renilla luminescence was 
then measured. Wells were measured in the same order on each plate when measuring Firefly 
and Renilla luminescence. Nontransfected cells were used to assess background luminescence 
(for both Firefly and Renilla luciferase) and this background was subtracted from all 
luminescence readings. Firefly luciferase luminescence was then normalized to Renilla 
luminescence to account for differences in transfection efficiency. Finally, a relative response 
ratio (RRR) is then calculated in order to evaluate the results in the context of the positive and 
negative controls, using the following equation:  
 
RRR = experimental sample ratio − negative control ratiopositive control ratio − negative control ratio  
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2.15 STATISTICAL ANALYSES 
 
Data are presented as means ±SEM. Statistical analyses were performed using GraphPad Prism® 
5.0 and p-values of <0.05 were considered statistically significant. mRNA levels in VSMC 
primary cultures from WKY and SHR rats were analyzed by a two-tailed t-test. Serum starvation 
mRNA and protein data, as well as mammalian two-hybrid data, were analyzed by one-way 
analysis of variance (ANOVA) with Tukey’s Multiple Comparison test. Tissue mRNA levels, 
MTT assay data, and cell count data were analyzed by two-way ANOVA followed by 
Bonferroni posttests. MTT assay data were also subjected to nonlinear regression and analyzed 
by F test.   																										
			
60	
3 RESULTS 
3.1 DIFFERENTIAL EXPRESSION OF GPSM3 IN WKY AND SHR RATS 
 
RNA was extracted from WKY-derived and SHR-derived VSMCs, reverse transcribed, and 
subjected to qPCR. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA 
levels. GPSM3 transcript levels were significantly increased in SHR-derived VSMCs relative to 
WKY-derived VSMCs by approximately two-fold (p < 0.05) (Figure 3.1). GPSM3 transcript 
levels were also assessed in various tissues from WKY and SHR rats to ascertain whether or not 
this model of hypertension resulted in changes to GPSM3 levels as is seen in vascular smooth 
muscle cells. The investigated tissues included heart, aorta, liver, lung, spleen, and leukocytes. 
RNA was extracted from these tissues, reverse transcribed, and subjected to qPCR. GPSM3 
mRNA levels were assessed relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
mRNA levels. The GPSM3 expression profile obtained from these tissues is comparable to that 
seen in previous studies (Cao et al. 2004; Zhao et al. 2010). GPSM3 transcript levels in the heart 
and liver were low relative to the spleen, leukocytes, and lungs (Figure 3.2). Furthermore, 
GPSM3 transcript levels were shown to be relatively high in aortic tissue for the first time. 
GPSM3 levels were significantly increased in the spleen of SHR rats relative to WKY rat spleen, 
with a p value less than 0.01. No significant differences were observed in the other tissues.  
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Figure 3.1. GPSM3 mRNA levels in WKY-derived and SHR-derived VSMCs. GPSM3 
mRNA levels were assessed relative to β2-microglobulin mRNA levels. Data are presented as 
means ± SEM of seven independent experiments (N=7) performed in triplicate. Statistical 
analysis was done using an unpaired t-test. *P<0.05. 
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Figure 3.2. GPSM3 mRNA levels in different WKY and SHR rat tissue types. GPSM3 
mRNA levels were assessed relative to GAPDH mRNA levels. Data are presented as means ± 
SEM of three to four independent experiments (N≥3) performed in triplicate. Statistical analyses 
were done using two-way ANOVA followed by Bonferroni posttests. **P<0.01. 
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3.2 GPSM3 EXPRESSION AND RATE OF CELL DIVISION 
 
VSMCs were serum starved by using serum-free medium to induce reversible cell cycle arrest 
(Chen et al. 2012). This was followed by the reintroduction of serum-containing medium to 
induce synchronized progression through the G2 and M phases of the cell cycle, simulating an 
increased rate of proliferation (Chen et al. 2012). Actively proliferating cells not subjected to this 
protocol were used as a control. Overall RNA and protein synthesis is relatively unaffected by 
the protocol (Zetterberg & Sköld 1969). Therefore, changes in gene expression can be indicative 
of that gene playing a role in the rate of cell division.  
 
Protein and mRNA levels were measured in both WKY- and SHR-derived VSMCs. GPSM3 
mRNA levels in WKY-derived VSMCs showed no changes in response to serum starvation and 
serum replacement (Figure 3.3). GPSM3 mRNA levels in SHR-derived VSMCs, however, 
showed a significant decrease in response to serum starvation (p value less than 0.05), and levels 
returned to control levels following serum replacement (Figure 3.4). GPSM3 mRNA levels were 
assessed relative to β2-microglobulin mRNA levels. GPSM3 protein could not be detected by 
immunoblot in cell lysates from WKY-derived VSMCs (Figure 3.5). The same trend observed 
with mRNA in SHR-derived VSMCs was found with GPSM3 protein levels (Figure 3.6). 
GPSM3 protein levels decreased in response to serum starvation, and returned to levels 
comparable to control levels following serum replacement.  
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Figure 3.3. Effect of serum deprivation and serum replacement on GPSM3 mRNA levels in 
WKY-derived VSMCs. Cells were treated for 48 hours with serum-free medium (serum dep.), 
followed by 48 hours of medium with 10% FBS (serum rep.). Actively proliferating cells were 
used as a control. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA 
levels. Data are presented as mean ± SEM of three to five independent experiments (N≥3) 
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by 
Tukey’s Multiple Comparison test. 
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Figure 3.4. Effect of serum deprivation and serum replacement on GPSM3 mRNA levels in 
SHR-derived VSMCs. Cells were treated for 48 hours with serum-free medium (serum dep.), 
followed by 48 hours of medium with 10% FBS (serum rep.). Actively proliferating cells were 
used as a control. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA 
levels. Data are presented as mean ± SEM of five to eight independent experiments (N≥5) 
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by 
Tukey’s Multiple Comparison test. *P<0.05. 
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Figure 3.5. 
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Figure 3.5 (previous page). Effect of serum deprivation and serum replacement on GPSM3 
protein levels in WKY-derived VSMCs. (A) Cells were treated for 48 hours with serum-free 
medium (serum dep.), followed by 48 hours of medium with 10% FBS (serum rep.). Actively 
proliferating cells were used as a control. GPSM3 protein levels were assessed relative to β-
tubulin protein levels. Data are presented as mean ± SEM of three independent experiments 
(N=3). Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple 
Comparison test. (B) Representative immunoblot of serum deprivation and replacement 
experiment. The upper immunoblot was probed for GPSM3 protein. The lower immunoblot was 
probed for β-tubulin protein.   
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Figure 3.6. 
Co
ntr
ol
24
h s
eru
m 
de
p.
48
h s
eru
m 
de
p.
24
h s
eru
m 
rep
.
48
h s
eru
m 
rep
.
0.0
0.1
0.2
0.3
0.4
G
PS
M
3/
β
-t
ub
ul
in
			
69	
Figure 3.6 (previous page). Effect of serum deprivation and serum replacement on GPSM3 
protein levels in SHR-derived VSMCs. (A) Cells were treated for 48 hours with serum-free 
medium (serum dep.), followed by 48 hours of medium with 10% FBS (serum rep.). Actively 
proliferating cells were used as a control. GPSM3 protein levels were assessed relative to β-
tubulin protein levels. Data are presented as mean ± SEM of five independent experiments 
(N=5). Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple 
Comparison test. (B) Representative immunoblot of serum deprivation and replacement 
experiment. The upper immunoblot was probed for GPSM3 protein. The lower immunoblot was 
probed for β-tubulin protein.   
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HEK-293 cells were transfected with 400 ng of either EYFP or EYFP-GPSM3 DNA plasmid and 
plated at approximately 8% confluency. Transfection of cells with EYFP-GPSM3 resulted in 
greater absorbance readings on day 1 and day 2 relative to the cells transfected with EYFP with p 
values less than 0.01 and 0.05, respectively (Figure 3.7). Cell populations transfected with 
EYFP-GPSM3 appeared to reach confluence one day earlier, or 33% faster, compared to the 
control cell populations. To further analyze the data, nonlinear regression was performed using 
an exponential plateau equation to compare the growth rates of the two groups of cells. The 
growth rate plus or minus standard error of cells transfected with EYFP-GPSM3 plasmid was 
0.7228 ± 0.1076 days-1 with a doubling time of 0.96 ± 0.14 days. The growth rate of cells 
transfected with EYFP plasmid was 0.3935 ± 0.0962 days-1 with a doubling time of 1.76 ± 0.43 
days. An F test was conducted, where both data sets were fit simultaneously with common 
minimum and maximum values and independent values of the growth rate k (either independent 
between data sets or forced to be common between the two data sets). Holding the parameter 
common for the two data sets caused a significant decrease in the goodness of the fit (as 
indicated by an increase in the sum of the squares), thus indicating that they are significantly 
different with a p value less than 0.05. Therefore, the growth rate of the cells transfected with 
EYFP-GPSM3 was found to be significantly higher than the control group.  
 
The results of counting cells expressing EFYP-GPSM3 or EYFP were similar to those obtained 
by the MTT assay. Cells transfected with EYFP-GPSM3 had a significantly higher cell 
population size on day 2 compared to those transfected with EYFP (Figure 3.8). Thus, higher 
rates of cell division are correlated with higher levels of GPSM3, and increasing the expression 
of GPSM3 appears to be sufficient to increase the rate of proliferation of cells.  
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Figure 3.7. Effect of EYFP-tagged GPSM3 transfection on cell proliferation in HEK-293 
cells as measured by MTT assay. HEK-293 cells were transfected with either EYFP-GPSM3- 
or EYFP-encoding DNA plasmid and seeded in a 24-well plate. Cells were treated with MTT 
reagent for 2 hours and then formazan crystals were recovered and solubilized in DMSO. 
Absorbance was measured at 595 nm. Data are presented as mean ± SEM of five independent 
experiments (N=5) performed in triplicate. Statistical analyses were done using two-way 
ANOVA followed by Bonferroni posttests. *P<0.05. **P<0.01. 
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Figure 3.8. Effect of EYFP-tagged GPSM3 transfection on cell proliferation in HEK-293 
cells as measured by cell counting. HEK-293 cells were transfected with either EYFP-GPSM3- 
or EYFP-containing plasmid and seeded in a 24-well plate. Cell counts were performed using 
ImageJ software. Data are presented as mean ± SEM of three independent experiments (N=3) 
performed in triplicate. Statistical analyses were done using two-way ANOVA followed by 
Bonferroni posttests. *P<0.05. 
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3.3 GPSM3 LOCALIZATION DURING MITOSIS IN VASCULAR SMOOTH MUSCLE 
CELLS 
 
N values for images of each cell type during each stage of mitosis can be found in Table 3.1. In 
interphase, GPSM3 localized to the nucleus with limited expression in the cytosol in both WKY 
and SHR vascular smooth muscle cells (Figure 3.9). Little to no co-localization between GPSM3 
and β-tubulin was observed during interphase. Cells in metaphase showed clear co-localization 
between GPSM3 and β-tubulin, presumably along the mitotic spindle fibers that attach to 
chromatin lined up at the metaphase plate (Figure 3.10A). The same co-localization of GPSM3 
and β-tubulin was seen during anaphase as the chromatin were pulled to opposite ends of the 
dividing cells (Figure 3.11A). Finally, co-localization was observed between GPSM3 and β-
tubulin during telophase at the midbody (Figure 3.12A).  
 
As a control, primary antibodies were incubated overnight at 4 °C with 10 µg/ml anti-GPSM3 
primary antibody blocking peptide before use in order to confirm that the anti-GPSM3 primary 
antibody was in fact binding specifically to GPSM3 protein. After incubation, 
immunofluorescent labeling was carried out as described previously. Co-localization between 
GPSM3 and β-tubulin was no longer seen during metaphase (Figure 3.10B), anaphase (Figure 
3.11B), or telophase (Figure 3.12B). Any remaining fluorescence seen with the anti-GPSM3 
primary antibody and the AlexaFluor 468 goat anti-rabbit secondary antibody can be attributed 
to non-specific binding by the anti-GPSM3 primary antibody. To further confirm the validity of 
this antibody for immunofluorescent labeling, HEK-293 cells were subjected to a protocol 
identical to that for WKY VSMCs. No co-localization was observed between GPSM3 and β- 
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Table 3.1. N values of immunofluorescently labeled images of vascular smooth muscle cells 
and human embryonic kidney 293 cells in different stages of mitosis. 
 
Stage of 
Mitosis 
VSMC VSMC  (with blocking peptide) HEK-293 
WKY SHR WKY SHR 
Interphase 8 8 0 0 0 
Metaphase 13 3 3 3 5 
Anaphase 4 3 3 3 3 
Telophase 11 3 0 3 0 
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Figure 3.9. Localization of GPSM3 and β-tubulin during interphase in WKY and SHR 
vascular smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 
hours, and following serum replacement (20 hours for WKY cells, 12 hours for SHR cells) cells 
were fixed and subjected to immunofluorescent labeling. Cells were probed with anti-GPSM3 
primary antibody (1:500) and anti-β-tubulin primary antibody (1:500), followed by AlexaFluor 
488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary 
antibody (1:500). Nuclei were stained using DAPI. Panels labeled in top left corners. Cell type 
indicated by label to left of panels. Cells imaged are representative of the majority of cells 
imaged. 
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Figure 3.10. 
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Figure 3.10 (previous page). Co-localization of GPSM3 and β-tubulin during metaphase in 
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were 
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours 
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed 
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500), 
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568 
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in 
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody 
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10 
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged 
are representative of the majority of cells imaged. 
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Figure 3.11. 
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Figure 3.11 (previous page). Co-localization of GPSM3 and β-tubulin during anaphase in 
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were 
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours 
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed 
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500), 
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568 
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in 
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody 
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10 
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged 
are representative of the majority of cells imaged. 
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Figure 3.12. 
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Figure 3.12 (previous page). Co-localization of GPSM3 and β-tubulin during telophase in 
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were 
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours 
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed 
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500), 
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568 
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in 
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody 
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10 
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged 
are representative of the majority of cells imaged. 
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tubulin antibody signals in HEK-293 cells (Figure 3.13). Similar to the observation of non-
specific binding in vascular smooth muscle cells when anti-GPSM3 primary antibody blocking 
peptide was used, diffuse and non-specific staining was seen in HEK-293 cells as well. 
Additional controls were also used to confirm the validity of these antibodies for 
immunofluorescent labeling. GPSM3 and β-tubulin were labeled independently from one another 
to ensure neither antibody was influencing the localization of the other (Figures 3.14 and 3.15). 
Immunofluorescent labeling with only the secondary antibodies was performed to demonstrate 
that these antibodies were not responsible for the observed localization of patterns (Figure 3.16).  
 
3.4 MAMMALIAN TWO-HYBRID ASSAY FOR GPSM3 PROTEIN INTERACTORS 
 
The heterotrimeric G protein subunits tested were as follows:  Gαi1, Gαi2, Gαo, GαoQ205L, 
Gαs, and Gβ1 (Figure 3.17). As expected, the assay showed an interaction between GPSM3 and 
both Gαi1 and Gαi2. Both interactions gave strong positive signals that were statistically 
significant relative to the negative control (p value less than 0.001). Gαs and Gαo did not 
produce a detectable signal. Gαo-Q205L, a form of the Gαo subunit containing a mutation that 
renders it constitutively active, failed to produce a signal significantly greater than that of the 
negative control. No interaction was detected between GPSM3 and Gβ1 either. As expected, all 
negative vector controls failed to produce detectable signals (Figure 3.18).   
 
			
83	
 
Figure 3.13. Localization of GPSM3 and β-tubulin during metaphase in HEK-293 cells. 
HEK-293 cells were serum starved for 24 hours, and 20 hours after serum replacement cells were 
fixed and subjected to immunofluorescent labeling. Cells were probed with anti-GPSM3 primary 
antibody (1:500) and anti-β-tubulin primary antibody (1:500), followed by AlexaFluor 488 goat 
anti-rabbit secondary antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary antibody 
(1:500). Nuclei were stained using DAPI. Panels labeled in top left corners. Cell type indicated 
by label to left of panels. Cells imaged are representative of the majority of cells imaged. 
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Figure 3.14. Localization of GPSM3 during metaphase and telophase in WKY vascular 
smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 hours, 
and 20 hours following serum replacement cells were fixed and subjected to immunofluorescent 
labeling. Cells were probed with anti-GPSM3 primary antibody (1:500), followed by AlexaFluor 
488 goat anti-rabbit secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled 
in top left corners. Cell cycle stage indicated by label to left of panels. Cells imaged are 
representative of the majority of cells imaged. N=3. 
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Figure 3.15. Localization of β-tubulin during metaphase and telophase in WKY vascular 
smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 hours, 
and 20 hours following serum replacement cells were fixed and subjected to immunofluorescent 
labeling. Cells were probed with anti-β-tubulin primary antibody (1:500), followed by 
AlexaFluor 568 goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. 
Panels labeled in top left corners. Cell cycle stage indicated by label to left of panels. Cells 
imaged are representative of the majority of cells imaged. N=3. 
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Figure 3.16. Localization of secondary antibodies during metaphase and telophase in WKY 
vascular smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 
hours, and 20 hours following serum replacement cells were fixed and subjected to 
immunofluorescent labeling. Cells were probed with AlexaFluor 488 goat anti-rabbit secondary 
antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary antibody (1:500). Nuclei were 
stained using DAPI. Panels labeled in top left corners. Cell cycle stage indicated by label to left 
of panels. Cells imaged are representative of the majority of cells imaged. N=3. 
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Figure 3.17. 
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Figure 3.17 (previous page). Mammalian Two-Hybrid luciferase assay results between 
GPSM3 and heterotrimeric G proteins. DNA plasmids were made by subcloning genes of 
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then 
transiently transfected into HEK-293 cells and luminescence was measured to detect protein-
protein interactions. (A) indicates that the protein’s corresponding gene has been subcloned into 
the pACT vector. (B) indicates that the protein’s corresponding gene has been subcloned into the 
pBIND vector. All data are presented as luciferase/Renilla output, which has been normalized to 
the positive and negative control values to produce a relative response ratio (RRR). Data are 
presented as mean ± SEM of three to eight independent experiments (N≥3) performed in 
triplicate. Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple 
Comparison test. ***P<0.001. 
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Figure 3.18. 
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Figure 3.18 (previous page). Mammalian Two-Hybrid luciferase assay results of 
heterotrimeric G protein vector controls. DNA plasmids were made by subcloning genes of 
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then 
transiently transfected into HEK-293 cells and luminescence was measured to detect protein-
protein interactions. (A) indicates that a gene has been subcloned into the pACT vector. (B) 
indicates that a gene has been subcloned into the pBIND vector. All data are presented as 
luciferase/Renilla output, which has been normalized to the positive and negative control values 
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three 
independent experiments (N=3) performed in triplicate. Statistical analyses were done using one-
way ANOVA followed by Tukey’s Multiple Comparison test. 
. 
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Proteins associated with cell division are the second class of proteins tested for interaction with 
GPSM3 (Figure 3.19). NuMA and ninein both failed to produce a statistically significant signal. 
GPSM3 also failed to interact with itself. As expected, all negative vector controls failed to 
produce detectable signals (Figure 3.20).  
 
The third and final class of proteins consists of those predicted to interact with GPSM3 by online 
databases (Figure 3.21). SELPLG failed to produce a detectable signal. FGFR3 and supervillin 
both produced positive signals above that of the negative control, however neither or these 
signals were statistically significant as assessed using ANOVA followed by Tukey’s Multiple 
Comparison test. As expected, all negative vector controls failed to produce detectable signals 
(Figure 3.22). 
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Figure 3.19. 
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Figure 3.19 (previous page). Mammalian Two-Hybrid luciferase assay results between 
GPSM3 and mitosis-related proteins of interest. DNA plasmids were made by subcloning 
genes of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, 
were then transiently transfected into HEK-293 cells and luminescence was measured to detect 
protein-protein interactions. (A) indicates that a gene has been subcloned into the pACT vector. 
(B) indicates that a gene has been subcloned into the pBIND vector. All data are presented as 
luciferase/Renilla output, which has been normalized to the positive and negative control values 
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three 
independent experiments (N=3) performed in triplicate. Statistical analyses were done using one-
way ANOVA followed by Tukey’s Multiple Comparison test. 
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Figure 3.20. 
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Figure 3.20 (previous page). Mammalian Two-Hybrid luciferase assay results of mitosis-
related gene of interest vector controls. DNA plasmids were made by subcloning genes of 
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then 
transiently transfected into HEK-293 cells and luminescence was measured to detect protein-
protein interactions. (A) indicates that a gene has been subcloned into the pACT vector. (B) 
indicates that a gene has been subcloned into the pBIND vector. All data are presented as 
luciferase/Renilla output, which has been normalized to the positive and negative control values 
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three 
independent experiments (N=3) performed in triplicate. Statistical analyses were done using one-
way ANOVA followed by Tukey’s Multiple Comparison test. 
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Figure 3.21. 
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Figure 3.21 (previous page). Mammalian Two-Hybrid luciferase assay results between 
GPSM3 and online database-predicted interactors. DNA plasmids were made by subcloning 
genes of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, 
were then transiently transfected into HEK-293 cells and luminescence was measured to detect 
protein-protein interactions. (A) indicates that the protein’s corresponding gene has been 
subcloned into the pACT vector. (B) indicates that the protein’s corresponding gene has been 
subcloned into the pBIND vector. All data are presented as luciferase/Renilla output, which has 
been normalized to the positive and negative control values to produce a relative response ratio 
(RRR). Data are presented as mean ± SEM of three to five independent experiments (N≥3) 
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by 
Tukey’s Multiple Comparison test. 
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Figure 3.22. 
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Figure 3.22 (previous page). Mammalian Two-Hybrid luciferase assay results of online 
database-predicted interactor vector controls. DNA plasmids were made by subcloning genes 
of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were 
then transiently transfected into HEK-293 cells and luminescence was measured to detect 
protein-protein interactions. (A) indicates that a gene has been subcloned into the pACT vector. 
(B) indicates that a gene has been subcloned into the pBIND vector. All data are presented as 
luciferase/Renilla output, which has been normalized to the positive and negative control values 
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three 
independent experiments (N=3) performed in triplicate. Statistical analyses were done using one-
way ANOVA followed by Tukey’s Multiple Comparison test. 
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4 DISCUSSION 
4.1 SUMMARY OF NOVEL FINDINGS 
 
The functional role of GPSM3 in the cell remains poorly understood, especially compared to 
other components of the G protein-mediated signaling machinery. I hypothesized that GPSM3 
plays a role in cell division, likely via an as yet undefined interaction with the mitotic spindle. In 
this study, GPSM3 transcript and protein levels were shown to be elevated in vascular smooth 
muscle cells (VSMCs) taken from spontaneously hypertensive (SHR) rats compared to those 
from normotensive Wistar-Kyoto (WKY) rats. In addition, a profile of GPSM3 transcript levels 
was compiled for the first time from rat tissues. SHR spleen tissue had higher levels of GPSM3 
transcript compared to its WKY counterpart. GPSM3 transcript levels were also detected in 
aortic tissue at relatively high levels for the first time. 
 
While heterotrimeric G protein subunits and GPSM motif-containing proteins have been linked 
to cell division, such a role for GPSM3 has not been reported in the literature. The results of the 
present study suggest that GPSM3 is indeed connected to the process of cell proliferation. In the 
SHR VSMCs with elevated GPSM3 expression, depriving cells of serum to promote cell cycle 
arrest resulted in decreased GPSM3 transcript and protein levels. Re-adding serum to these cells, 
allowing them to reenter the cell cycle, led to transcript and protein levels returning to control 
levels. GPSM3 expression seems to be linked to which stage of the cell cycle a cell is in. These 
results also suggest that GPSM3 expression is regulated at the level of transcription. Two 
independent experimental methods, an MTT assay and cell counting, showed that overexpression 
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of EYFP-GPSM3 in HEK-293 cells results in an increased proliferation rate. This indicates that 
changing GPSM3 expression is sufficient to significantly alter a cell’s rate of proliferation. 
 
Immunofluorescent labeling in WKY and SHR VSMCs revealed that GPSM3 co-localizes with 
β-tubulin during mitosis. During metaphase and anaphase, GPSM3 appears to localize to the 
microtubules as they attach to and pull apart chromatin. In cytokinetic cells, GPSM3 localizes to 
the microtubules in the midbody. These results suggest that GPSM3 functions in cell division via 
interaction with the mitotic spindle and could influence spindle orientation, spindle position, and 
chromosome segregation. Finally, the mammalian two-hybrid assay does not support previous 
observations that GPSM3 interacts with Gβ1 and Gαo. The assay also provided evidence against 
a number of hypothesized protein-protein interactions involving GPSM3. 
 
Ultimately, the results of this study support the hypothesis that GPSM3 is involved in the process 
of cell division. Expression of GPSM3 in VSMCs is linked to being in the cell cycle and 
increasing expression increases proliferation rate. GPSM3 likely exerts its function in cell 
division through an as yet undefined interaction with the mitotic spindle. 
 
4.2 CONTRIBUTION OF RESEARCH TO CURRENT STATE OF KNOWLEDGE 
 
Findings from this study have furthered our state of knowledge in three main categories: general 
knowledge about GPSM3, our understanding of cell division, and, to a lesser extent, our 
understanding of hypertension. 
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4.2.1 CONTRIBUTION TO OUR GENERAL KNOWLEDGE OF GPSM3 
 
The expression profile compiled from GPSM3 transcript levels in WKY and SHR rat tissues 
(Figure 3.2) partially supports previously reported profiles from mouse and human tissues (Cao 
et al. 2004; Zhao et al. 2010). The finding that GPSM3 is moderately to highly expressed in 
spleen, lung and leukocytes is similar to mouse and human tissue. However, the finding that 
levels of GPSM3 mRNA in heart and liver are relatively low is at odds with reports from mouse 
and human tissues. For the first time, it is reported that GPSM3 transcript is present at high 
levels in aortic tissue at well. These findings also contradict the assertion by Billard et al. 2014 
that GPSM3 expression is highly restricted to immune system cells.  
 
Immunofluorescent labeling of vascular smooth muscle cells in interphase showed GPSM3 to be 
enriched in the nucleus and faintly detectable throughout the cytosol (Figure 3.9). Previous 
reports show GPSM3 mainly present in the cytosol or enriched at the plasma membrane (Cao et 
al. 2004; Giguère et al. 2013; Giguère, Laroche, Oestreich, Duncan, et al. 2012; Giguère, 
Laroche, Oestreich & Siderovski 2012; Willard et al. 2008; Zhao & Chidiac 2015). However, the 
COMPARTMENTS Subcellular localization database uses a sequence-based subcellular 
localization prediction method to predict that GPSM3 would be distributed similarly to the 
results seen in this study: enriched in the nucleus and present in the cytosol (Binder et al. 2014). 
It is worth noting that these cells were primed to divide by first serum starving them and then 
giving them serum-containing medium again in order to synchronize their cell cycles. This was 
not performed on any of the cells imaged in previous reports.  
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Regulation of GPSM3 expression has been studied very little. It has been reported that GPSM3 
expression in immune cells changes in response to differentiation, but the underlying mechanism 
remains unclear (Giguère et al. 2013; Gall, Schroer, et al. 2016). Our finding that GPSM3 
transcript and protein levels change to a similar degree in response to serum starvation and serum 
replacement (Figures 3.4 and 3.6) suggest that GPSM3 protein levels are modulated by 
transcriptional regulatory mechanisms rather than via translational or post-translational 
mechanisms, such as altered degradation. Two single nucleotide polymorphisms (SNPs) of the 
human GPSM3 gene result in decreased transcript abundance due to reduced promoter activity 
and these are inversely correlated with rheumatoid arthritis prevalence (Gall, Wilson, et al. 
2016). Considering GPSM3 deficiency has been shown to act as a protective factor in a mouse 
model of inflammatory arthritis (Giguère et al. 2013), our finding that GPSM3 is likely 
transcriptionally regulated recalls the earlier report that GPSM3 SNPs that reduce transcript 
abundance result in decreased rheumatoid arthritis risk. It would be interesting to see if these 
polymorphisms are correlated with other disease states, especially hypertension and cancer.  
 
In agreement with our findings (Figure 3.17), GPSM3 has been reported by multiple studies to 
interact with Gαi subunits while it does not interact with Gαs (Zhao et al. 2010; Cao et al. 2004; 
Kimple et al. 2004; Robichaux et al. 2015; Giguère, Laroche, Oestreich & Siderovski 2012; 
Giguère, Laroche, Oestreich, Duncan, et al. 2012; Oner, Maher, et al. 2010). However, unlike 
previous reports, our findings do not show that GPSM3 interacts with Gαo (Zhao et al. 2010) or 
Gβ1 (Giguère, Laroche, Oestreich & Siderovski 2012). Gαo and a mutationally activated variant, 
GαoQ205L, were both tested and neither returned statistically significant signals. GαoQ205L 
was used to mimic the fluoroaluminate-activated version of Gαo that Zhao et al. 2010 showed 
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was capable of interacting with GPSM3. GαoQ205L has had a glutamine at position 205 mutated 
to become a leucine, and this is thought to result in persistent activation by inhibiting the GTPase 
activity of the protein (Kroll et al. 1992). On the other hand, fluoroaluminate activates Gα 
subunits by binding to the GDP-binding site next to GDP and mimicking the role of the γ-
phosphate of GTP (Bigay et al. 1985). The resulting structure more closely resembles that of the 
transition state for GTP hydrolysis than the ground state of an active Gα subunit (Kleuss et al. 
1994). Therefore, GαoQ205L may be a more physiologically relevant model of activated Gαo 
and this could account for the different results of these two studies.  
 
Giguère et al. 2012 reported that GPSM3 is capable of interacting with the Gβ subunits Gβ1 to 
Gβ4. Their study suggested that GPSM3 acts as a stabilizing chaperone of neosynthesized Gβ 
subunits during transport to the plasma membrane and that the binding site overlaps the N-
terminal side of the first GPSM motif in GPSM3. Other than in that study, no GPSM motif-
containing protein has yet been reported to interact with Gβ subunits. This finding could not be 
replicated using Gβ1 in the mammalian two-hybrid assay. If GPSM3 does indeed act as a 
chaperone for Gβ subunits, the signal shuttling them to the plasma membrane could potentially 
interfere with the two-hybrid assay by preventing the DNA-binding domain from associating 
with the luciferase reporter gene, thereby precluding the promotion of luciferase protein 
synthesis by the transcriptional activation domain. 
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4.2.2 CONTRIBUTION TO OUR KNOWLEDGE OF HYPERTENSION 
 
Increased GPSM3 expression in vascular smooth muscle cells from SHR rats relative to WKY 
rats (Figure 3.1) could be a protective factor in response to hypertensive conditions. Many 
pathological conditions of the cardiovascular system such as hypertension, hypertrophy, and 
heart failure have been linked to altered Gαi/o-mediated signaling (Sato & Ishikawa 2010). This 
altered signaling is likely an adaptive response of the cardiovascular system. Gαi/o-mediated 
signaling in the vasculature of SHR rats is reported to be elevated (Kost et al. 1999). Expression 
of Gαi2/3 in the heart and Gαi2 in the aorta were reported to be increased in SHR rats compared 
to WKY rats, while Gαs was unchanged (Anand-Srivastava 1992). Hypertension in SHR rats can 
also be delayed by temporally inactivating Gαi/o-mediated signaling via pertussis toxin treatment 
(Li & Anand-Srivastava 2002). Therefore, the inhibitory effect of GPSM3 on Gαi/o activation 
could play a protective role in hypertension.  
 
Increased GPSM3 expression in SHR VSMCs could also be a causative factor in the 
hypertensive phenotype of SHR rats. The transition of smooth muscle cells from a contractile to 
a proliferative, migratory phenotype is associated with cardiovascular disease (Dzau et al. 2002; 
Fingerle et al. 1989; Sandison et al. 2016). Changes in GPSM3 expression have been linked to 
differentiation, with higher GPSM3 levels associated with more mobile cell types (Giguère et al. 
2013; Gall, Schroer, et al. 2016). Our finding that GPSM3 overexpression results in increased 
proliferation (Figures 3.7 and 3.8) suggests that elevated GPSM3 in SHR VSMCs could foster a 
more proliferative phenotype, thus leading to hypertension. Interestingly, blood pressure control 
mechanisms in GPSM1 null mice are altered, as sensitivity to the vasodilator sodium 
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nitroprusside (SNP) and baroreceptor reflex sensitivity were both reported to be elevated, while 
the ability to return to pre-SNP arterial pressure levels was impaired (Blumer et al. 2008). 
 
Finally, I also found that GPSM3 transcript levels are increased in SHR spleen tissue. 
Hypertension is associated with increased immune activity (Sun et al. 2006). As immune cells, 
particularly monocytes, are known to have relatively high GPSM3 expression, and the spleen has 
been shown to act as a reservoir for the majority of monocytes in the body, this could account for 
the higher levels of GPSM3 in SHR spleen tissue compared to spleen tissue from WKY rats 
(Giguère et al. 2013; Swirski et al. 2009). Alternatively, GPSM3 deficiency in mice has been 
linked to a decreased inflammatory response and decreased GPSM3 transcript levels in humans 
are linked with decreased arthritis risk (Giguère et al. 2013; Gall, Wilson, et al. 2016). The heart, 
brain, kidneys, and liver are reported to be inflamed in SHR rats (Sun et al. 2006). If the spleen is 
also inflamed in these rats, this could account for the increased levels of GPSM3 transcript.  
 
4.2.3 CONTRIBUTION TO OUR KNOWLEDGE OF CELL DIVISION 
 
G proteins and GPSM motif-containing proteins play essential roles in the process of cell 
division. Our data provide evidence of a role for GPSM3 in cell division for the first time. 
GPSM3 expression appears to be linked to the cell cycle (Figures 3.4 and 3.6). Depriving SHR 
VSMCs of serum in order to arrest the cell cycle resulted in GPSM3 mRNA levels significantly 
decreasing and GPSM3 protein levels following a similar trend. Reintroducing serum into the 
medium to allow re-entry into the cell cycle led to transcript and protein levels returning to 
normal. GPSM2 and Gαi3 expression also change during the cell cycle, being upregulated during 
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metaphase in mammalian cells (Blumer et al. 2006). Expression of other protein classes, such a 
cyclins and cyclin-dependent kinases (CDKs), also vary throughout the cell cycle and can 
determine the proliferative fate of a cell (Yang et al. 2006; Shankland et al. 1996).  
 
Overexpressing EYFP-tagged GPSM3 in HEK-293 cells resulted in an increased proliferation 
rate, as measured by both MTT assay and cell counting (Figures 3.7 and 3.8). Therefore higher 
levels of GPSM3 are correlated with higher rates of cell division, and increasing the expression 
of GPSM3 appears to be sufficient to increase proliferation rates. This could partly explain why 
SHR VSMCs, which have higher GPSM3 transcript and protein levels than WKY VSMCs 
(Figures 3.1, 3.5, and 3.6), divide at a rate approximately 1.75 times greater than their WKY 
counterparts (Hadrava et al. 1991). In addition, this could give insight into the elevated levels of 
GPSM3 in aortic tissue taken from abdominal aortic aneurism (AAA) (Lenk et al. 2007). AAA is 
associated with a decreased number of smooth muscle cells; therefore GPSM3 levels may be 
elevated in the smooth muscle cells in order to stimulate proliferation. However, an alternate 
explanation could be that the elevated levels of GPSM3 are a result of the immune cells known 
to infiltrate aortic tissue in AAA. GPSM3 expression is relatively high in immune cells and these 
cells could be responsible for the elevated GPSM3 levels reported.  
 
The present findings may also indicate a role for GPSM3 in cancer biology. GPSM3 expression 
increases by greater than two-fold in prostate cancer models which mimic angiogenesis (Lapan 
et al. 2009). Furthermore, GPSM3 has been identified as a gene required for the proliferation of 
p53 human cancer cell lines (Xie et al. 2012). GPSM2 levels are elevated in most breast cancer 
cell lines and knocking down GPSM2 in those cells results in significant growth suppression and 
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incomplete cell division (Fukukawa et al. 2010b). Since elevated GPSM3 levels correlate with 
and may in fact cause increased rates of cell division, GPSM3 could be an attractive therapeutic 
target for cancer treatment. 
 
GPSM3 was observed to co-localize with β-tubulin at the spindle fibers during metaphase and 
anaphase (Figures 3.10 and 3.11), and at the midbody during telophase (Figure 3.12). GPSM2 
has been shown to localize to these same regions during these three stages of mitosis as well in 
breast cancer cells (Fukukawa et al. 2010b). Gαo co-localizes with β-tubulin at the mitotic 
spindle in animal and human cell lines as well (Wu & Lin 1994), and Gβ subunits are 
incorporated into the mitotic spindle and interact with tubulin in bovine brain cells according to 
Wu et al. 1998. Gαi2, on the other hand, has been reported to bind to the kinetochores of 
chromatin in 3T3 cells (Crouch & Simson 1997). Since GPSM2 has been reported to directly 
interact with Gαo and that overexpression of Gαo subunits are capable of redirecting localization 
of GPSM2 in the cell, it is likely that GPSM2 is being recruited to the spindle fibers by Gαo 
(Kaushik et al. 2003). Our findings also suggest that GPSM3 interacts with Gαi1 and Gαi2 
(Figure 3.17). Therefore GPSM3 may be recruited to the spindle fibers by one of the members of 
the Gαi/o family.  
 
Considering the many parallels between the findings of this study and previous reports on 
GPSM2, I propose that GPSM3 may function in a similar capacity to GPSM2. The tertiary 
complex consisting of Gαi, GPSM2, and NuMA plays a critical role in the generation of pulling 
forces on the mitotic spindle and spindle pole orientation and positioning (Du & Macara 2004; 
Merdes et al. 2000; Tall & Gilman 2005). Rapid cycling of nucleotide exchange on the Gαi 
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subunit is thought to contribute to these pulling forces, and is accomplished by GAP and GEF 
activity of accessory proteins (Tall & Gilman 2005; Dave et al. 2009). GPSM3 could be part of 
an alternative complex that plays a related but different role from GPSM2 in cell division. It is a 
particularly attractive candidate for such a role as its reported GEF activity could aid rapid 
cycling of nucleotide exchange (Zhao et al. 2010).   
 
4.3 EXPERIMENTAL METHODS: NOTES AND LIMITATIONS 
4.3.1 SERUM STARVATION  
 
This study used serum starvation to induce reversible cell cycle arrest (Chen et al. 2012), which 
has been shown to not change overall RNA and protein synthesis in a cell (Zetterberg & Sköld 
1969). Changes in GPSM3 transcript and protein levels were therefore thought to be the result of 
changes in the cell cycle. However, serum starvation is a potent cellular stress and it cannot be 
ruled out that GPSM3 expression changes in response to cellular stress. It should also be noted 
that serum starvation has been shown to induce transcriptional changes in pathways related to 
cancer, cell death, apoptosis, and the cell cycle in the LoVo colon cancer cell line (Zheng et al. 
2016). 
 
4.3.2 EYFP-TAGGED GPSM3 
 
In the MTT assay and cell counting experiments, HEK-293 cells were transiently transfected 
with either EYFP-tagged GPSM3 or EYFP. The difference in proliferation rates between these 
two groups of cells was attributed to GPSM3. Since linking a fluorescent protein to a protein of 
			
110	
interest and the position of this linkage can affect the localization and functionality of that 
protein of interest (Snapp 2005), it is conceivable that the same effect would not occur using 
untagged GPSM3. 
 
4.3.3 MAMMALIAN TWO-HYBRID ASSAY 
 
I failed to identify any novel GPSM3 interactors using the mammalian two-hybrid assay. The 
proteins of interest that were tested were chosen for specific reasons. NuMA was chosen due to 
its functional role with GPSM2 and the many similarities between GPSM3 and GPSM2. Ninein 
was chosen because it plays a role in anchoring microtubules to the centrosome and due to its 
high expression in the vasculature of normal and pathological human tissues, making it an 
attractive target (Matsumoto et al. 2008; Mogensen et al. 2000). Neither of these proteins when 
tested produced statistically significant signals (Figure 3.19). Previously in our lab, a co-
immunoprecipitation assay using His-tagged GPSM3 as bait and probing for β-tubulin failed to 
indicate that the two proteins directly interact or co-exist in a complex. For this reason, β-tubulin 
was not included in the list of proteins to test for interaction with GPSM3.  
 
The remaining three proteins, FGFR3, supervillin, and SELPLG, were chosen because they were 
predicted as likely GPSM3 interactors by the web resource STRING (Search Tool for the 
Retrieval of INteracting Genes) database (Szklarczyk et al. 2015). In addition to making its own 
predictions, STRING also uses protein-protein interaction prediction data and resources from 
over twenty other online resources. GPSM motifs can be regulated via phosphorylation 
(Hollinger et al. 2003; Blumer et al. 2003; Fukukawa et al. 2010b) and FGFR3 contains a 
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cytosolic tyrosine kinase domain (Keegan et al. 1991; Bocharov et al. 2013). I therefore reasoned 
that FGFR3 could be regulating GPSM3 via its kinase activity. SELPLG shares many of the 
associations GPSM3 has, being linked to cardiovascular disease (Tregouet et al. 2003; Volcik et 
al. 2009), inflammation (Sun et al. 2016), and cell migration, and reported expression in immune 
cells (Luan et al. 2010). GPSM2 and NuMA require Afadin, an actin-binding protein, for proper 
cortical localization via direct interaction between GPSM2 and Afadin (Carminati, Gallini, et al. 
2016; Carminati, Cecatiello, et al. 2016). Supervillin contains actin-binding sites and is 
associated with cell motility and cancer (Fedechkin et al. 2013). I predicted that supervillin might 
interact with GPSM3 in a role analogous to that of Afadin with GPSM2. None of these proposed 
interactions were confirmed by the mammalian two-hybrid assay (Figure 3.21). It should be 
noted that SELPLG no longer appears as a predicted GPSM3 interactor in the STRING database 
since it was updated. The intragenic microRNA database still lists SELPLG as a GPSM3 
interactor, listing STRING as its source (miRAD 2016). 
 
Mammalian Two-Hybrid assays have the potential to produce false negative results. First, the 
size and orientation of the proteins of interest could interfere with the ability of the fused DNA-
binding domain and transcriptional activation domain from coming into close contact and 
promoting the synthesis of luciferase. Supervillin, ninein, and NuMA are all over 2000 amino 
acids in length, which could have interfered with the ability of the fused domains from coming 
into close contact. Second, the fused domains could sterically hinder the ability of the proteins of 
interest to associate (Lievens et al. 2009). These situations likely account for vector 
directionality, as observed with the tested interaction between GPSM3 and Gαi1/2 (Figure 3.17). 
Third, one or more of the proteins of interest may be tethered to a part of the cell preventing the 
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complex from coming into contact with the reporter gene. For example, supervillin may be 
tethered to actin filaments via its actin-binding domains. Finally, if the tested proteins are part of 
a larger complex, other components of the complex may need to be overexpressed as well in 
order for the complex to form and a signal to be produced.  
 
4.4 FUTURE DIRECTIONS 
 
The results of this study provide strong evidence of a role for GPSM3 in cell division. The 
specific function of GPSM3 and how it achieves that function remain to be elucidated. 
Overexpression of GPSM3 was shown to increase the rate of proliferation of cells. Future studies 
should determine whether using siRNA to knockdown the level of GPSM3 in a cell produces the 
opposite effect, decreasing proliferation rate. If this is indeed the case, targeted gene therapy 
against GPSM3 could be a potential treatment for certain cancers. Knockdown of GPSM1 and 
GPSM2 homologues in C. elegans leads to incorrect spindle orientations and decreased spindle 
pulling forces (Srinivasan et al. 2003; Schneider & Bowerman 2003b). Overexpression of 
GPSM2 in kidney cells results in oscillations and rotations of the mitotic spindle which indicate 
strong pulling forces being exerted on astral microtubules (Du & Macara 2004). Future 
experiments should overexpress and knock down GPSM3 to determine whether a similar 
phenotype occurs.  
 
GPSM3 null mice have been successfully bred (Giguère et al. 2013). Considering GPSM3 is 
elevated in SHR VSMCs and they divide at a faster rate than WKY VSMCs (Hadrava et al. 
1991), measuring the proliferation rate in VSMCs taken from GPSM3 null mice would be 
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interesting. Spindle orientation and pulling forces should also be studied in the smooth muscle 
cells and compared to those that endogenously express GPSM3. If proliferation rate is indeed 
decreased in these VSMCS, overexpressing GPSM3 in these cells to rescue a normal division 
rate phenotype could strengthen the argument that GPSM3 levels are correlated with 
proliferation rate. 
 
Coupling between GPSM motif-containing proteins and Gα proteins is necessary for mitosis to 
occur properly. Blocking this interaction via a point mutation which prevents the GPSM motif 
from binding to Gαi results in cytokinetic defects and abnormal mitotic spindle rocking (Willard 
et al. 2008; Cho & Kehrl 2007). It is also possible to mutate the GPSM motifs in GPSM3 so that 
they are incapable of interacting with Gα subunits (Zhao et al. 2010). Studying the mitotic 
spindle and cytokinesis in cells that have this mutation could help demystify the role GPSM3 
plays in cell division.  
 
Finally, like GPSM2, GPSM3 most likely interacts with other proteins in order to fulfill its role 
in cell division. Therefore identifying these interaction partners would be an important step in 
determining the function of GPSM3. This study suggests that despite sharing many similarities 
with GPSM2, GPSM3 may not interact with the same proteins. Online resource databases such 
as STRING also appear to struggle to correctly predict GPSM3 interactors. Therefore, a yeast 
two-hybrid assay could be used to screen a smooth muscle cell cDNA library for proteins that 
interact with GPSM3. Identifying GPSM3 interaction partners could be the turning point in 
ascertaining its function in cell division. 
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4.5 CONCLUSIONS 
 
Our results provide evidence that GPSM3 plays a role in the process of cell division. GPSM3 
levels are correlated with changes in the cell cycle of vascular smooth muscle cells from 
spontaneously hypertensive rats. Overexpression of EYFP-tagged GPSM3 in HEK-293 cells 
results in a significant increase in the proliferation rate of those cells. Furthermore, in vascular 
smooth muscle cells, GPSM3 co-localizes with β-tubulin at the mitotic spindle during metaphase 
and anaphase and at the midbody during telophase. Therefore, GPSM3 appears to play a role in 
the process of cell division, likely via interaction with the mitotic spindle.  																												
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6 APPENDIX 1 
5.1 SUPPLEMENTAL FIGURES 
Localization of GPSM3 during mitosis was first investigated by transfecting HEK-293 cells with 
EYFP-tagged GPSM3 plasmid and labeling β-tubulin using anti-β-tubulin primary antibody and 
AlexaFluor 555 goat anti-rabbit secondary antibody (Figure 5.1). During metaphase, EYFP-
GPSM3 and β-tubulin appear to co-localize. However, it was difficult to resolve how specific 
this co-localization was. Additionally, capturing cells undergoing mitosis was difficult using this 
protocol as cells first needed to be transfected and allowed to recover before having their cell 
cycles synced via removal and re-addition of serum-containing medium. For these reasons, 
successive experiments labeled endogenous GPSM3 using an anti-GPSM3 primary antibody and 
AlexaFluor 488 goat anti-rabbit secondary antibody. β-tubulin was stained using anti-β-tubulin 
primary antibody and AlexaFluor 568 goat anti-mouse secondary antibody.  
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Figure 5.1. Localization of EYFP-tagged GPSM3 during mitosis in HEK-293 cells. HEK-
293 cells were transfected with 1 µg EYFP-GPSM3 DNA plasmid. Cells were serum starved for 
24 hours, and 20 hours after serum replacement cells were fixed and subjected to 
immunofluorescent labeling. Cells were probed with anti-β-tubulin primary antibody (1:500), 
followed by AlexaFluor 555 goat anti-rabbit secondary antibody (1:500). Nuclei were stained 
using DAPI. Panels labeled in top left corners. N=3.  																								
EYFP-GPSM3 β-tubulin DAPI Merge 
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5.2 ANIMAL PROTOCOL APPROVAL FORM 
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